Safety and Pharmacological profile of Panchakkini Chenduram by Savitha, S
SAFETY AND PHARMACOLOGICAL PROFILE OF 
PANCHAKKINI CHENDURAM 
 
The dissertation Submitted by 
Dr. S.SAVITHA 
 
Under the Guidance of 
Dr.S.Visweswaran, M.D(S) 
H.O.D.(i/c)& Guide, Department of Gunapadam, 
National Institute of Siddha. 
 
Dissertation Submitted to 
 
The Tamil Nadu Dr. M.G.R. Medical University, Chennai – 32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the partial fulfillment of the requirements to the Degree of 
 
 
DOCTOR OF MEDICINE (SIDDHA) 
 
BRANCH II - DEPARTMENT OF GUNAPADAM 
2014-2017 
 
NATIONAL INSTITUTE OF SIDDHA 
Chennai – 47  
 
 
 
 
 
 
ACKNOWLEDGEMENT 
 
 
 
 
 
 
 
ACKNOWLEDGEMENT 
 
v This dissertation is one of the milestones in the journey of my professional carrier 
as it is the key program in acquiring my MD(S) degree. Thus I came across this 
task which kept on completed with the support and encouragement of numerous 
people. So I take great pleasure in thanking all the people who made this 
dissertation study a valuable and successful one, which I owe to treasure it. 
 
v I  feel  enormous  wonder  and  colossal  gratitude  in  my heart  of  hearts  to  
GOD and SIDDHARS  Almighty for making this dissertation have its present 
form. 
 
v I express my sincere thanks to the Vice-Chancellor, The Tamilnadu Dr.MGR 
medical University, Chennai-32. 
 
v I express my profound sense of gratitude to Prof. Dr.V.Banumathi M.D(s), 
Director, National Institute of Siddha, Chennai-47. 
 
v I expressmy sincere thanks to Dr.S.Visweswaran M.D(s),H.O.D.i/c & Guide, 
Department of Gunapadam, National Institute of Siddha, Tambaram sanatorium 
Chennai-47, for his valuable suggestions and guidance in this dissertation work. 
 
v I express my sincere thanks to Dr.S.Sivakkumar M.D(s), Lecturer, Department 
of Gunapadam, NIS, Chennai-47 for his suggestions, hopeful support and 
encouragement of my whole study. 
 
v I express my sincere thanks to Dr.A.Mariappan M.D(s), Lecturer, Department of 
Gunapadam, NIS, Chennai-47, for his suggestions, hopeful support and 
encouragement of my whole study. 
v I express my sincere thanks to Dr.V.Suba M.Pharm.,Ph.D., Assistant Professor 
in Pharmacology, NIS, Chennai-47, for her suggestions in the pharmacological 
study. 
v I express my sincere thanks to Dr.M.Suresh Gandhi M.Sc.,M.Phill.,Ph.D., 
Assistance Professor, Department of Geology, University of Madras, Chennai-600 
025, identification and authentification of Minerals. 
v I express my grateful thanks to Dr.P.Muralidharan IAEC Member Secretary, 
C.L.Baid Metha College of Pharmacy, Jyothi Nagar, Old Mahabalipuram Road, 
Thoraipakkam, Chennai- 600 097, for his assistance in the Pharmacological and 
Toxicological study.   
 
v I express my sincere thanks to Regional Research Institute of Unani 
Medicine(RRIUM) No.1, West Madha Church Road, Royapuram, Chennai – 13 
 
v I express my sincere thanks to Centre for Advance Research in Indian System of 
Medicine (CARISM), Sastra University,  Tirumalaisamudram, Thanjavur 613401, 
Analysis study results. 
 
v I express my sincere thanks to Sathyabama University, Chennai – 600 119, 
interpretation for analysis studies. 
 
v I express my sincere thanks to Mr.M.Subramanian, M.Sc., (Statistics) Senior 
Research Officer, National Institute of Siddha, Chennai-47. 
 
v I express my gratefulness to All My Colleagues and My friends for lending their 
helping hands whenever needed during the course of the study.  
 
v I express my thanks to each and every faculties of NIS, Library staffs and Lab 
staffs. 
 
Last but not least, I would like to pay high regards to all my family members, my 
Father Mr.N.Seeralan, my mother Mrs.C.Tamilarasi and my Sisters for their sincere 
encouragement throughout my research work and lifting me uphill this  phase of life. I 
owe everything to them. Besides this, several people have knowingly and unknowingly 
helped me in the successful completion of this project. 
 
 
 
 
 
 
 
 
 CONTENTS 
 
S.NO TITLE P.NO 
1 INTRODUCTION 1 
2 AIM AND OBJECTIVES 3 
3 REVIEW OF LITERATURE 4 
 
 
 
3.1 MINERALOGICAL ASPECT 4 
3.2 ZOOLOGICAL ASPECT 22 
3.3 PHARMACEUTICAL ASPECT 25 
 
  4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIAL AND METHODS 
26 
 
4.1 
 
SOP OF TRIAL DRUG 
26 
 
4.2 
 
ANALYTICAL STUDY OF TRIAL DRUG 
32 
 
4.2.1 
 
PHARMACOGNOSTICAL STUDY 
32 
 
4.2.1.1 
 
ORGANOLEPTIC EVALUATION 
32 
 
4.2.2 
 
PHYSICOCHEMICAL ANALYSIS 
33 
 
4.2.3 
 
CHEMICAL ANALYSIS 
34 
 
4.2.4 
 
FT- IR  ANALYSIS 
39 
 
4.2.5 
 
XRD ANALYSIS 
40 
 
4.2.6 
 
SEM ANALYSIS 
42 
 
4.2.7 
 
UV ANALYSIS 
43 
  
 
 5 
TOXICOLOGICAL  STUDY 
 
45 
 
5.1  ACUTE TOXICITY STUDY 
49 
 
5.2   REPEATED DOSE 28 DAYS ORAL 
TOXICITY 
51 
 
 5.3 REPEATED DOSE 90 DAYS ORAL 
TOXICITY 
55 
 
6 PHARMACOLOGICAL STUDIES 
59 
 
6.1 HEPATOPROTECTIVE ACTIVITY     
59 
 
6.2 DIURETIC ACTIVITY                  
61 
 
6.3 HEMATINIC ACTIVITY            
63 
 
7 RESULTS  
65 
 
8 DISCUSSION 
124 
 
9 SUMMARY                              
128 
 
10 CONCLUSION 
129 
 
11 ANNEXURE 
130 
 
12 BIBILIOGRAPHY 
135 
 
 
 
 
 
 
 
INTRODUCTION 
 
1 
 
1. INTRODUCTION 
 
Siddha system is the one of the ancient system of medicine in the world. Siddhars 
are the pioneers of Siddha system of medicines. It includes 32 types of internal and 32 
types of external medicines. The siddha drugs have been prepared from herbs, metals, 
minerals and animal resources. A total number of 4448 diseases are mentioned in siddha 
text as well as with line of treatment. 
 
The term ‘Siddhar’ has derived from the word ‘Siddhi’ which literally means 
accomplished, achieved or perfected success and so it refers to one who had attained his 
end in spiritual goal. 
 
The major contributions of Siddhars are classified as follows  
 Alchemy  
 Medicine  
 Meditation  
 Knowledge 
 
Back to medicine, Siddhars had an unparalleled knowledge of medicine 
preparation. The worldly objects are classified under the following three divisions  
 Plant kingdom  
 Mineral kingdom and   
 Animal kingdom 
 
In Siddha, Chenduram (calcined red oxide) is one of the greatest higher order 
medicines. It is a Metallic substance or toxic salts are made into red coloured powder, by 
the process of either burning or drying them or exposing to the sunlight or keeping them 
in specialized tubes by adding decoction, liquid of victory (ceyaneer), acid etc.. 
 
Chenduram is a very effective medicine even in small dose and it has the longer 
shelf life even upto 75 years. It can be given with the sustained adjuvant. The outcome of 
this medicine is faster also has the ability to treat chronic and medically challenging 
diseases but should be prepared in a proper method. 
 
Chenduram has the energy to postponed the ageing process. So, the energy of 
Karpa Chenduram is much greater than the Karpa plants. 
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The saint Agasthiyar and Yagoppu have written books on Chenduram namely 
Agasthiyar Chenduram 800, Loga Chenduram 300 and Chendura Soothiram 150 
respectively. 
 
Panchakkini Chenduram is one among the mineral formulation mentioned in the 
text Anuboga vaidya navaneetham, vol 1 page 92 Author- Hakkim Abdulla shayabu. 
 
The ingredients of “Panchakkini chenduram” are Purified Arappodi (Iron), 
Purified Kaantham (Magnetic Oxide of Iron), Sangu Chunnam (Conch Shell), Purified 
Nellikkai Gandhagam (Sulphur) and PurifiedNavacharam (Ammonium Chloride). 
According to the Siddha text, ingredients of Panchakkini chenduram is mentioned as 
therapeutically effective for Manjal Noi (Liver disease), Paandu (Anaemia), Neerkattu 
(Oliguria). 
 
Panchakkini Chenduram has not been scientifically validated so far and author 
has selected  Panchakkini chenduram for the evaluation of safety study, Hepatoprotective 
activity, Diuretic and Hematinic activity. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
AIM AND OBJECTIVES 
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2. AIM AND OBJECTIVES 
 
AIM 
 To evaluate the safety and pharmacological aspect of the test drug “Panchakkini 
Chenduram" in animal models. 
 
OBJECTIVES 
Panchakkini Chenduram has been evaluated in the following aspects. 
1. Collection of evidence in Siddha literature. 
2. Collection of evidence in mineral and metals. 
3. Pharmacognostical study of the test drug. 
4. Physicochemical, chemical and phytochemical analysis of test drug. 
 
5. Toxicity studies 
v Acute oral toxicity study of the drug by OECD-423 Guideline. 
v 28 days Repeated oral toxicity study of the drug by OECD-407 Guideline. 
v 90 days Repeated oral toxicity study of the drug by OECD-408 Guideline. 
 
6. Pharmacological activities in Wister albino rats 
 
v Hepatoprotective activity by Paracetamol induced method. 
v Diuretic activity by Lipschitz method. 
v Hematinic activity by Phenyl hydrazine method. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
 
  
 
 
 
 
MINERALOGICAL ASPECT 
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3. REVIEW OF LITERATURE 
 
3.1  MINERALOGICAL ASPECT 
 
IRON 2,3,4 
 
GENERAL PROPERTIES 
Name   :          Iron 
 Empirical formula :          Feo   
Symbol   : Fe 
     Appearance               : lustrous metallic with a tinge 
 
Ø Iron is an essential mineral that contributes too many important 
physiologic functions in the body. 
Ø Much of the iron in the body is attached to hemoglobin molecules in red 
blood cells, thereby delivering oxygen to all of the tissues. 
Ø Extra iron is stored in the liver, bone marrow, spleen and muscles. 
 
VERNACULAR NAMES 
Tamil   : Irimbu 
  Sanskrit  : Lauha, hyam 
  Malayalam  : Basi 
  Telugu   : Inumu 
Urdu    : Lohchun  
   
SOURCE 
Ø Widely distributed in both the organic and inorganic kingdoms. 
Ø Found in nearly all rocks, soils, etc, variously combined with oxygen as 
haematite, with sulphur as iron pyrites. 
Ø Found in the ashes of plants and even the blood (RBC of the blood) of 
animals and also in the bile, chyle, gastric juice, lymph, milk, pigment of 
the eye and in the urine. 
Ø The largest iron resources in the world are in China, Russia, Brazil, 
Canada, Australia and India. 
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FOOD SOURCES OF IRON 
 
          Good sources of iron include, 
Ø Liver 
Ø Meat  
Ø Beans  
Ø Nuts 
Ø Fruits (such as dried apricots) 
Ø Whole grains (such as brown rice) fortified breakfast cereals 
Ø Soybean flour  
Ø Most dark green leafy vegetables (such as watercress, curly kale & spinach)  
 
PHYSICAL PROPERTIES 
Ø Iron is a silvery-white or grayish metal. 
Ø It is ductile and malleable. 
Ø Iron has a very high tensile strength. 
 
  Melting point  : 1,536ºC (2,797ºF) 
  Boiling point  : 3,000ºC (5,400ºF) 
  Color    : Iron black, Dark gray, Steel gray  
  Density   : 7.3-7.9, Average = 7.6 
  Diaphaneity   : Opaque 
Fracture  : Hackly – Jagged, torn surfaces,  
(eg: fractured   Metals)     
  Hardness   : 4-5- Fluorite-Apatite 
  Luminescence  : Non-fluorescent 
  Luster    : Metallic 
  Magnetism   : Naturally strong 
  Streak   : Gray 
 
CHEMICAL PROPERTIES 
Ø Iron is a very active metal. 
Ø It readily combines with oxygen in moist air.  
Ø The product of this reaction, iron oxide (Fe2 o3) is known as rust. 
Ø Iron also reacts with very hot water and steam to produce hydrogen gas. 
Ø It also dissolves in most acids and reacts with many other elements. 
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ACTION 
 
Ø Iron improves the quality of blood. 
Ø Iron stimulates the functional activity of all organs of the body and is 
therefore a valuable general tonic. 
 
BENEFITS AND FUNCTIONS OF IRON 
 
Iron is of tremendous value to the human body. It is involved in the formation of 
red blood cells and is a transporter of oxygen to every cell, providing us with the 
necessary burst of energy we all need to help us through our daily tasks. 
 
Iron also assists the memory and the ability to concentrate and helps build 
resistance to infection, stress and disease. 
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«Âõ 
Ayyam (Iron)14 
 
§ÅÚ ¦ÀÂ÷¸û 
 
v «¸¢ v «ÂÍ v þÊ v þÕõÒ 
v ®º ¦ºÂõ v ¸Õí¦¸¡ø v ¸ÕôÀ¢ v ¸ÕõÒ 
v ¸ÕÁ½ø v ¸Õõ¦À¡ý v ¸ÂÍ v ¸¢Õ‰½¨ÅÂõ 
v ¸¡Ä¢ø¦¿¸¢Çõ v ¬¾¢ v ºòÐ v º¢§Ã¡ºÃõ 
v º¢ð¼õ v ¾¢ÕõÀ¢ v Ðñ¼õ v À¢ñ¼õ 
v ¦À¡ýÁ½ø v §Ä¡¸õ v ¸Õó¾¡Ð v «Â¢ø 
v Å¡úâÁ¢ ¿¡¾õ    
  
Í¨Å  
 
     ¦ÀÕõÀ¡ý¨Á ÐÅ÷ôÒ, º¢ÚÀ¡ý¨Á ÒÇ¢ôÒì ¨¸ôÒ 
 
 
Å£Ã¢Âõ  
 
     ¦ÅôÀõ 
 
¦ºö¨¸ 
 
v Àº¢Ôñ¼¡ì¸¢ 
v ¯¼ø ¯ÃÁ¡ì¸¢ 
v ÌÕ¾¢ ¦ÀÕì¸¢ 
v ¯¼ø §¾üÈ¢ 
 
¦À¡ÐìÌ½õ 
 
 "À¡ñÎ¦Åñ Ìð¼õ ÀÕóàÄ §¿¡ö§º¡¨À 
      Á¡ñÊ¼î¦ºö Áó¾¸¡ Á¡¨ÄÌýÁõ âñ¼ 
      ¦ÀÕó¾¡Ð ¿ð¼Óõ§À¡õ §À¾¢Àº¢ Ôñ¼¡í 
      ¸Õó¾¡Ð ¿ð¼Á¢Îí ¸¡ø." 
 
8 
 
¾£Õõ À¢½¢¸û 
 
v À¢ò¾ À¡ñÎ 
v ¦Åñ Ìð¼õ 
v «¾¢àÄõ §¿¡ö 
v §º¡¨À 
v Áó¾õ 
v ¸¡Á¡¨Ä 
v ÌýÁõ 
v Íì¸¢Ä¿ð¼õ 
v ¸Æ¢îºø. 
v Àº¢ ¯ñ¼¡ìÌõ. 
 
Íò¾¢ 
  
þÕõÀ¢ý «Ãô¦À¡Ê¨Â ±ÖÁ¢îºõ ÀÆîº¡Ú, ¸¡Ê, ¿¡ðÎì ¸¡ð¼¡½ìÌô 
À¡ø þ¨Å ´ù¦Å¡ýÈ¢Öõ ãýÚ ¿¡û °È ¨ÅòÐì ¸ØÅ¢ ±Îì¸î Íò¾¢Â¡õ. 
 
«Ç× 
 
v ¯ò¾Áô À¢ÃÁ¡½õ-º¡¨ÁÂÃ¢º¢ «Ç× 
v Áò¾¢Áô À¢ÃÁ¡½õ-¾¢¨É «Ç× 
v «¾Áô À¢ÃÁ¡½õ -¦¿øÄÃ¢º¢ 
¿¡û «Ç× 
 
v ¯ò¾Áõ-ÓôÀò¾¢ÃñÎ ¿¡û 
v Áò¾¢Áõ-À¾¢¦ÉðÎ ¿¡û 
v «¾Áõ -ÀýÉ¢ÃñÎ ¿¡û 
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MAGNETIC OXIDE OF IRON5, 6 
 
Chemical formula     -          Fe3o4 
           Empirical formula     - Fe3+2Fe2+o4 
 
Ø Magnetite is one of the most common oxide minerals and also one of the most 
common iron minerals. Chemical formula (Fe3o4)   
Ø Magnetite is the most magnetic of all the naturally occurring minerals on Earth. 
Ø The chemical IUPAC name is iron (II, III) oxide and the common chemical name 
is Ferrous – Ferric oxide. 
 
SOURCE 
 
          Magnetite also occurs in many sedimentary rocks, including banded iron formation. 
 
PHYSICAL PROPERTIES 
Cleavage  :   none 
Color    : Grayish black, Iron black 
Luster    : metallic to sub metallic 
Magnetism  : Naturally strong 
 Streak    : Black 
Hardness   : 5.5-6.5 
Diaphaneity    : Opaque 
Specific gravity          : 5.2 
Luminescence   : Non- fluorescent 
 Density    : 5.1-5.2, average =5.15 
Fracture    : Sub conchoidal-fractures developed in brittle  
materials Characterized by semi curving surfaces 
Curie temperature      : 858k(585ºC,1085ºF) 
 
CHEMICAL PROPERTIES  
 
          Magnetite reacts with oxygen to produce hematite and mineral which forms a 
buffer that can control oxygen fugacity.   
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USES OF MAGNETITE 
 
Ø Important ore of iron 
Ø Abrasive  
Ø Toner in electro photography 
Ø Heavy media for specific gravity separations 
Ø Micronutrient in fertilizer, pigment in paints 
Ø An aggregate for high-density concrete 
 
¸¡ó¾õ 
 
KAANTHAM (MAGNETIC OXIDE OF IRON)14 
 
§ÅÚ ¦ÀÂ÷¸û 
 
v º¢Å§Ä¡¸î §ºÅ¸ý v ¾Ã½¢ìÌ ¿¡¾õ 
v ¿Å§Ä¡¸ò ÐÃðÊ        v ¸¡Âº¢ò¾¢ìÌô À¡ò¾¢Ã Å¡ý 
v Ý¾ «íÌºõ             v ÓÕ¸ý ÒÃ¡½õ 
 
¦ºö¨¸ 
 
v ÌÕ¾¢ô¦ÀÕì¸¢  
v Àº¢Ôñ¼¡ì¸¢  
v ¯¼ø§¾üÈ¢  
v ¯¼ø ¯ÃÁ¡ì¸¢. 
 
¦À¡ÐìÌ½õ 
 
 "¸¡ó¾ò¾¡ü §º¡¨ÀÌýÁí ¸¡Á¢Ä§Á ¸õÀ¡ñÎ 
 §º÷ó¾¾¢Ã¢ §¾¡¼¦Åð¨¼ º£¾í¸¡ø - µöó¾Àº¢ 
 §ÀÕ¾Ãí ¸ñ§½¡ö À¢ÃÁ¢Â¿£ Ã¡¨ÁÔõ§À¡õ 
 µÃ¢É£¨È Â¡ÔÙÚõ ¯ý." 
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¾£Õõ §¿¡ö¸û 
 
v Å£ì¸õ 
v ÌýÁõ 
v ¸¡Á¡¨Ä 
v §Á¸õ 
v À¡ñÎ 
v Óò§¾¡¼õ 
v ¦Åû¨Ç Å£Æø 
v º£¾Çõ 
v Å¡¾§¿¡ö 
v Áó¾õ 
v Á§¸¡¾Ãõ 
v Å¢Æ¢§¿¡ö 
v À¢ÃÁ¢Âõ 
v ¿£Ã¡¨Áì¸ðÊ Ó¾Ä¢ÂÉ ¿£íÌõ. 
v âÃ½ ¬ÔÙõ ¯ñ¼¡õ. 
 
Íò¾¢ 
 
   ±ÖÁ¢îºõÀÆîº¡Ú, ÒÇ¢ò¾ì ¸¡Ê, ÒÇ¢ò¾ §Á¡÷ þ¨Å¸Ç¢ý Ó¨È§Â ÓõãýÚ 
¿¡û ¸¡ó¾ò¨¾ °È¨ÅòÐ ¦ÅÂ¢Ä¢ø ¨ÅòÐì ¸ØÅ¢ ±Îì¸î Íò¾¢Â¡õ. 
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SULPHUR4, 7, 8 
 
Ø Sulphur is a yellow, non-metallic element with medicinal properties. It has a  
Distinct “rotten egg” smell, caused by sulphur dioxide gas escaping into the air. 
Ø As a supplement, sulphur is available in two forms- dimethyl sulfoxide (DMSO) 
and methylsulfonylmethane (MSM). About 15% of DMSO breaks down into 
MSM in the body.  
Ø Both have been touted as treatments for pain. 
Ø Sulphur occurs in combination with many such as copper, iron etc. 
Ø  The chemical properties of sulphur and its compounds including the reaction with 
mercury, Hg to form a red solid, mercuric sulphide (H2S). 
 
SYNONYMS 
Ø Sulfur 
Ø Brime stone 
Ø Colloidal sulphur 
Ø Floor of sulphur 
Ø Corosal D & F 
 
VERNACULAR NAMES  
Tamil  :      Gandakam  
Sanskrit :  Gandhaka 
Malayalam :  Gendagum 
Telugu  :  Gandhakam 
Hindi  :           Gandak 
English :           Brimstone 
 
AVAILABILITY 
 Sulphur is procurable in bazaars in different forms myrobalan. Sulphur is used in 
medicine. It is procurable in all bazaars. It is crystalline in nature.  
SULPHUR-S 
 Atomic number   : 16 
 Atomic mass    : 32.6gmol-1 
 Electro negativity       :  2.5 
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 Density         : 2.07g.cm³ at 20 c 
 Melting point         : 113ºc 
 Boiling point         : 445ºc 
 Vanderwaals radius       :  0.127nm 
 Ionic radiation        :  0.184(-2)nm;0.029(+) 
 Isotopes         : 5 
 Electronic shell (Ne)       : 35-2 3p4 
 Energy of 1 ionisation      : 999.3kj.mol-1 
 Energy of 2 ionisation      : 2252kj.mol-1 
Energy of 3 ionisation     : 3357kj.mol-1 
Standard potential      :  -0.51v 
Discovered by       : The ancient 
 
FOOD SOURCES OF SULPHUR 
 
The main sulphur containing foods are red gram, green gram and leafy vegetables.  
A diet sufficient in protein is generally considered to be adequate in sulphur. 
 
DOSAGE OF SULPHUR 
 There is no official recommended dietary allowance or dietary reference. Intake 
for this mineral but as a guideline you need more than 100mg of sulphur per day. 
 
PHYSICO-CHEMICAL PROPERTIES 
Ø Sulphur is a multivalent, non-metal, abundant, tasteless & odorless. 
Ø It is yellow and crystalline solid. 
Ø In nature it is pure elements (or) sulphide minerals. 
Ø The smell of the sulphur compare to rotten egg smell, the presence odour because 
of hydrogen sulphide (H2S) 
Ø Sulphur presence naturally near the volcanoes. 
Ø Sulphur presence naturally as massive deposits in Texas & Louisian in U.S.A 
Canada is the main producer. 
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It is distributed in the world wide such as, 
Canada  :  22% 
Erusia    : 11% 
Saudhi Arabia  : 5% 
Germany & Poland  :     4% 
France   : 2% 
 
PHYSICAL PROPERTIES 
Symbol   : S 
Formula            : S8 
System             : Orthorhombic 
Atomic Number        : 16 
Colour   : Elemental Sulphur is a bright yellow crystalline solid 
Melting Point   : 115.2C 
Hardness  :  ½ to 2½ 
Atomic Mass  : 2.065+0.005u 
Density   :   2.07g/cm³  
 
CHEMICAL PROPERTIES 
Odour     : Odourless or Faint, rotten egg if not 100% pure 
Molecular Weight   : 256.50 
Solubility in Water  : Insoluble 
Boiling Point    : 832F 
Purity     : 90% to 100%  
 
HEALTH EFFECTS OF SULPHUR 
 
All living things need Sulphur because it is a part of amino acid. It is absolute 
dietary requirement, the average person takes in around 900 mg of sulphur /day. Mainly 
Sulphur is a macro nutrient present in both plants & animals. If a person does not gets 
enough Sulphur in their diet certain health problems such as  itchy, improper development 
of nails, very unusually the lack of sulphur leads to death.  
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GENERAL USES OF SULPHUR 
 Sulphur is commercially important in manufacture of chemical such as sulphuric 
acid. The chemicals are also used for manufacture of sulfa drugs. In agriculture, the 
Sulphur is the fore most important crop nutritive element and it is also used as a fertilizer, 
it is also used to manufacture Poultry feeds. Sulphur is used in medicines only after it is 
refined well. 
ACTION 
Ø Keratolytic Activity 
Ø Antifungal 
Ø AntiBacterial  Activity 
Ø Antimicrobial 
Ø Alterative and Tonic 
(Sulphur is said to clean the blood and help protect us against toxic build-up.) 
 
MEDICINAL USES  
 Sulphur is used in scabies. The fumes of burning Sulphur are said to cure gout and 
 rheumatic fever. Theorganic Sulphur reduces the motility and invasion of MDA-MB-231  
human breast cancer cells. It is also used as the following purposes in medical uses such 
as. acne, eczema, ring worm, indigestion, diarrhea, vomiting, belching, hemorrhoids and 
anal fissures especially for women, insomnia, premenstrual syndrome, headache, 
dizziness, perspiration, mental tension, lack of memory, depression, impotency, cold, 
cataract, bronchitis, migraine, fever and conjunctivitis. 
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¸ó¾¸õ 
GANDHAGAM (SULPHUR)14 
 
§ÅÚ ¦ÀÂ÷¸û 
 
v À¨Ã Å£Ã¢Âõ v ¸¡Ã¢¨ÆÂ¢ý ¿¡¾õ v «¾£¾ôÀ¢Ã¸¡ºõ 
v ¦ºøÅ¢Å¢óÐ v À£ºõ v ºì¾¢ 
v ¦ºóàÃò¾¡¾¢ v ºò¾¢À£ºõ v ¾Éõ 
v ¿¡¾õ v §¾Å¢ÔÃõ v ¿¡üÈõ 
v ¦À¡ýÅ÷½¢ v À¨Ã ¿¡¾õ v þÃº Í§Ã¡½¢¾õ 
 
Í¨Å 
¨¸ôÒ ÐÅ÷ôÒ 
¦ºö¨¸ 
v À¢ò¾¿£¨Ã «¾¢¸ôÀÎòÐõ 
v ÁÄÁ¢Çì¸¢ 
v ¯¼ø §¾üÈ¢ 
v Å¢Â÷¨Å ¦ÀÕì¸¢ 
v ¸¢ÕÁ¢¿¡º¢É¢ 
v §¾¡ø, «Í¸í¸û ºÇ¢î ºùÅ¢ÖûÇ §¸¡Çí¸Ç¢ý ÍÃô¨À «¾¢¸ôÀÎòÐõ. 
v Å¢§Ã¸¢Â¢ø º¢ÈôÀ¡¸î ¦ºÂøÀðÎ ÍÃô¨À «¾¢¸ôÀÎòÐõ. 
 
¦ÅÇ¢§ÂüÈõ 
 
v Å¢Â÷¨Å, À¡ø, º¢Ú¿£÷ þÅüÈ¢ý ÅÆ¢Â¡¸ ¦ÅÇ¢ôÀÎõ. 
v «¾¢¸ «ÇÅ¢ø «Õó¾ô §À¾¢¨Â ¯ñÎ ÀñÏõ. 
 
 
¦À¡ÐìÌ½õ 
 
 "¦¿øÄ¢ì¸¡öì ¸ó¾¢ìÌ ¿£ûÀ¾¢¦Éñ Ìð¼Áó¾õ 
 Åø¨Ä ¸Å¢¨ºÌýÁ Å¡Ô¸ñ§½¡ö - ¦À¡øÄ¡ 
 Å¢¼ì¸ÊÅý §Á¸§¿¡ö Å£ÚÍÃõ §À¾¢ 
 ¾¢¼ì¸¢Ã¸ ½£Àõ§À¡ó §¾÷." 
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¾£Õõ §¿¡ö¸û 
 
v À¾¢¦ÉñÌð¼õ 
v Áó¾õ 
v ¸øÄ£Ãø 
v Å£ì¸õ 
v ¦ÀÕÅÂ¢Ú Å¨¸¸Ùû ´ýÈ¡¸¢Â ¸Å¢¨º 
v ÌýÁÅ¡Ô 
v ¸ñ§½¡ö¸û ¦¸¡Î¨Á¨Âî ¦ºö¸¢ýÈ Å¢¼ì¸Ê¸û 
v ¿¡ðÀð¼ §Á¸ §¿¡ö¸û 
v Å¡¾ ÍÃõ 
v §À¾¢ 
v ¿¡ðÀð¼ ¸¢Ã¸½¢ ¸Àõ. 
 
 
§¾¨ÃÂ÷ ¦À¡Õð ÀñÒ áÄ¢ø, 
 
    ¾¡ö Á¸¨Å ÅÇ÷ôÀÐ §À¡Ä §¿¡ö¸Ç¢ý ¦ÅôÀò¨¾ Á¡üÈ¢ ¯¼õ¨Àò 
§¾üÈ¢ìÌ¦ÁýÀ¨¾, 
 
  "Á¡¾÷ Á¸¨Å ÅÇ÷ôÀÐ§À¡ §ÄÔ¼õ¨À 
   Â¡¾ÃÅ¡ ¸ò§¾üÈ¢ Â¡ì¨¸Â¢É¡ø-Á£¾¡¸" 
     ±ýÈ ÅÃ¢Â¡ø «È¢ÂÄ¡õ. 
 
Íò¾¢ 
 
¸ó¾¸ò¨¾ ´Õ þÕõÒì ¸ÃñÊÂ¢Ä¢ðÎî º¢È¢Ð ÀÍ¦Åñ¨½ö þðÎ 
¯Õì¸¢ô ÀÍõÀ¡Ä¢ø º¡öì¸×õ. þùÅ¢¾õ ÓôÀÐ Ó¨È ¦ºöÂì ¸ó¾¸õ 
Íò¾¢Â¡õ. ´ù¦Å¡Õ Ó¨ÈÔõ Ò¾¢Â À¡¨Ä§Â ¯À§Â¡¸¢ì¸ §ÅñÎõ. 
 
«Ç× 
 
650Á¢.¸¢Ã¡õ-1¸¢Ã¡õ (10-30 ¯Ùó¦¾¨¼)  
1 Ó¾ø 3ÅÃ¡¸¦É¨¼ (4.2¸¢Ã¡õ-12.6¸¢Ã¡õ) ¦¸¡Îì¸ ÁÄõ ¸Æ¢Ôõ. 
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AMMONIUM CHLORIDE – NAVACHARAM 9 
 
SYNONYMS  
Ø Sal ammoniac  
Ø Salmiac 
Ø Nushadir salt 
Ø Sal armagnac 
Ø Salt armoniack   
 
PROPERTIES 
Chemical fomula            : NH4Cl 
Molar mass                     : 53.49 g mol -1 
Appearance                     : White solid, hygroscopic 
Odour      : Odorless                             
Density                         : 1.5274g/cm³ 
Melting point                : 338ºc (640ºF;611k) decomposes,sublimes 
Boiling point                 : 520ºc (968ºF;793k) 
Solubility in water        : 244g/L(-15ºc) 
   294g/L(0ºc) 
   383.0g/L(25ºc) 
   454.4g/L(40ºc) 
   740.8g/L(100ºc) 
Solubility product            : 30.9(395g/L) 
Solubility                         : Soluble in liquid ammonia, hydrazine,  
alcohol, methanol, glycerol slightly Soluble 
in acetone. Insoluble in diethyl ether, ethyl 
acetate.   
Acidity       :  9.24    
 
ACTION  
Ø Caustic 
Ø Expectorant  
Ø Diuretic 
Ø Diaphoretic 
Ø Antibilious 
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FOOD 
Ø In several countries, ammonium chloride, under the name sal ammoniac or 
colloquially salmiak is used as food additive under the E number E510, commonly 
as a yeast nutrient in bread making. 
Ø It is a feed supplement for cattle and an ingredient in nutritive media for yeast and 
many microorganism. 
Ø Ammonium chloride is used to spice up dark sweets called salty liquorice (very 
popular in Nordic countries), in baking to give cookies a very crisp texture and in 
the liquor salmiakki koskenkorva for flavouring. In India and Pakistan, it is called 
“No shader” and is used to improve the crispness of snacks such as samosas and 
jalebi. 
 
MEDICINAL USES 
 
Ø Ammonium chloride is used as an expectorant in cough medicine. Its expectorant 
action is caused by irrigative action on the bronchial mucosa, which causes the 
production of excess respiratory tract fluid, which presumably is easier to cough 
up. 
Ø Ammonium salts are an irritant to the gastric mucosa and may induce nausea and 
vomiting. 
Ø Ammonium chloride is used as a systemic acidifying agent in treatment of severe 
metabolic alkalosis, in oral acid loading test to diagnose distal renal tubular 
acidosis to maintain the urine at an acid pH in the treatment of some urinary­tract 
disorders.    
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¿Å¡îº¡Ãõ 
NAVACHARAM (AMMONIUM CHLORIDE)14 
 
§ÅÚ ¦ÀÂ÷¸û 
 
v þ‰Ê¨¸       v ÝÇ¢¨¸ 
v ºøÄ¢¨¸      v ÀÎ 
 
¦ºö¨¸ 
 
v §¸¡¨ÆÂ¸üÈ¢ 
v Å¢Â÷¨Å ¦ÀÕì¸¢ 
v º¢Ú¿£÷ ¦ÀÕì¸¢ 
v Å¢Ã½ Óñ¼¡ì¸¢ 
v À¢ò¾Á¸üÈ¢ 
þÐ Óì¸¢ÂÁ¡¸ ¿¢½ ¿ÃõÒ¸û, Á¡Á¢ºì ¸¢Ãó¾¢¸û Á£Ð ¾ý §Å¸ò¨¾î 
¦ºÖòÐõ. 
 
¦À¡ÐìÌ½õ 
 
 "ÌýÁõ Ì¼üÝ¨Ä ¦¸¡øÖõ Á§¸¡¾Ãò¨¾ 
  Åý¨ÁÔÚ ¸øÄ¨¼ô¨À Á¡üÚí¸¡ñ- ºýÁì 
  ¸Å¢îÍÓò §¾¡¼í ¸ÉÅ¡¾ ¿£ìÌõ 
  ¿Åîº¡Ã Á¡§¾ ¿Å¢ø." 
 
¾£Õõ À¢½¢¸û 
 
v ÅÂ¢üÚÅÄ¢ 
v Ì¼Ä¢ø Ìò¾ø 
v ¦ÀÕÅÂ¢Ú 
v ¸øÄ¨¼ôÒ 
v ºÕÁò¾¢ø ÒÄ¡ø Å¡ºõ 
v ¾¢Ã¢§¾¡¼õ 
v ¸ÉÅ¡Ô þ¨Å¸¨Ç ¿£ìÌõ. 
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ÁüÚõ þ¨¾, 
v ¸øÄ£Ãø Å£ì¸õ 
v À¢Ä£¸ §¿¡ö 
v ¿£÷ì§¸¡¨Å þÃò¾ ¸¡ºõ 
v Ó¸îºó¾¢ 
v ÝÃ¢Â¡Å÷ò¾ Å¡¾õ 
v Ý¾¸ì¸ðÎ 
v ¸ì¸¢ÕÁø 
v Ó¨Èì¸¡öîºø 
v Å¢¼¡ì ¸¡öîºø þ¨Å¸ðÌõ ¯À§Â¡¸¢ì¸Ä¡õ. 
 
Íò¾¢  
 
§¸¡ãò¾¢Ãò¨¾ ¸¨ÃòÐ, ÅÊ¸ðÊî Íñ¼ ±Ã¢òÐ ¦ÅÂ¢Ä¢ø ¯Ä÷ò¾¢ 
±Îì¸î Íò¾¢Â¡õ. 
 
«Ç× 
 
2 1/2 ÌýÈ¢ (325Á¢.¸¢Ã¡õ) Ó¾ø 7 1/2 ÌýÈ¢ (975Á¢.¸¢Ã¡õ) Å¨ÃÂ¡Ìõ. 
«¾¢¸ «ÇÅ¢ø ¦¸¡Îì¸ §À¾¢Â¡Ìõ. 
 
 
 
 
 
 
ZOOLOGICAL ASPECT 
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3.2 ZOOLOGICAL ASPECT 
CONCH SHELL10, 11, 12, 13 
(SANGU) 
SYNONYM 
 
Xachus Pyrum 
Gastropoda  
     Conch is a common name that is applied to a number of different medium to 
large-size sea snails or their shells. 
 
SCIENTIFIC  : CLASSIFICATION  
 
Kingdom  :    Animalia  
Phylum  : Mollusca 
Class   :     Gastropoda 
Superorder    : Caenogastropoda 
Order     :    Sorbeoconch 
Suborder   : Hypsogastropoda 
Infraorder     : Littorinimorpha  
Superfamily     : Stromboidea 
Family   : Stromboidea 
Genus    : Strombus  
 
SPECIES 
Strombus gigas 
Strombus pugilis 
 
VERNACULAR NAME 
San & Born        -    Shankha 
 English   -  Conch; conch shell 
 Duk                     -  Sukk 
Geej, Mah,& Canada  -  Shankha 
 Tamil    -  Sanka, sangu 
 Bengal     - Sankh 
Source    - Indian ocean coasts 
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CHARACTERS 
 
A porcelaneous shell of an oblong or conical form, the oblong form is bulged is 
the middle and tapering at each end. The conical variety is peculiar. The upper portion is 
like cork screw, twisted and tapering at the end. The base is broad. The interior is hollow. 
The surface is hard of a dull white colour. The upper surface is highly tuberculated, the 
under surface shining, very brittle and translucent. 
 
FOOD 
 The meat of conch is eaten raw in salads or cooked, as in burgers, chowders, 
fritters, and gumbos. All parts of the conch meat are edible.  
 
HUMAN USES 
 
Ø The animals inside the shell are eaten either raw, as in salads or cooked as in 
fritters, chowders, gumbos and burgers. 
Ø In East Asian cuisines, the meat is often cut into thin slices and then steamed or 
stir-fried. 
Ø Conch meat is also often confused with scintilla, which is more accurately whelk 
meat. 
Ø Conch shells are sometimes used as decoration, as decorative planters, and in 
cameo making. 
 
BIOLOGICAL ACTIVITY 
 
Ø Conch shell is used in treating dyspepsia, digestion impairment, malabsorption 
syndrome and hepatomegaly. 
Ø Sankha bhasma is used for ear ache, ulcer and eye troubles and is indicated 
internally in case of dyspepsia, gonorrhoea, colic dysentery, jaundice, tymphanitis 
and flatulence. 
Ø Sankha bhasma is also used to treat catarrh, sorethroat, cough and asthma. 
 
ACTIONS 
Ø Nutrient 
Ø Anodyne 
Ø Expectorant 
Ø Carminative 
Ø Digestive 
Ø Astringent 
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ºíÌ 
SANGU (CONCH SHELL)14 
 
§ÅÚ ¦ÀÂ÷¸û 
 
v ¿óÐ            v Íò¾¢          v Å¨Ç 
v ¸õÒ            v §¸¡Î          v Å¡Ã½õ 
v ¦Åû¨Ç        v ÅñÎ v þ¼õÒÃ¢ 
v ºí¸õ          v §¾Å¾ò¾õ  
 
  ¦À¡ÐìÌ½õ 
 
"¸º¢Å¡ Á¢Ãò¾ À¢ò¾í ¸ñ§½¡ö¸ §ÇÌõ 
 Àº¢Â¡Úõ Å¡¾õ ÀÈìÌ - Á¢º¢×¼§É 
 ¾íÌ Ó¨ÇÅ¢Ã½ó ¾¡É¸Ö §Á¦Åû¨Çî 
 ºí¸ÁÐ ×ñ¼¡Â¢üÈ¡ý." 
 
¾£Õõ À¢½¢¸û 
 
v þÃò¾À¢ò¾õ 
v ¸ñ§½¡ö¸û 
v Å¡¾ Á¢Ì¾¢ 
v þº¢× 
v Ó¨Çì¸ðÊ Ó¾Ä¢ÂÉ ¿£íÌõ. 
v Àº¢ ¯ñ¼¡õ. 
 
¦ºö¨¸ 
 
v ¯¼ø ¯ÃÁ¡ì¸¢ 
v ÐÂÃ¼ì¸¢ 
v «¸ðÎÅ¡ÔÅ¸üÈ¢ 
v Àº¢ò¾£òàñÊ 
 
Íò¾¢ 
 
    ºí¨¸ì ¸üÍñ½¡õÀ¢ø Ò¨¾òÐò ¾¡Ç¢òÐì ¸ØÅ¢ ±Îì¸î Íò¾¢Â¡Ìõ. 
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3.3 PHARMACEUTICAL ASPECT  
 
Chenduram: 
         Metallic substances or arsenical compounds are made into red coloured powders by 
the process of burning, frying or insulating or keeping them in specialized pudams by 
grinding them with decoctions, ceyaneers juices etc.   
 
v Chendurams which become red by burning; Drugs such as Miruthyunjagam. 
v Chendurams which become red by frying; Drugs such as Ayaveera Chenduram. 
v Chendurams which become red by grinding; Drugs such as Chandamarutha 
Chenduram.  
v Majority of Chendurams used in day to day practice are like that of Aya 
Chenduram.   
 
Chenduram types: 
v Karruppu chenduram – Oxidium nigrum 
v Manjal chenduram – Oxidium flarrum  
v Sivappu chenduram – Oxidium rubrum  
v Seenaveeravaippu chenduram  
v Thiriloaga chenduram- red oxide of three metals 
v Naagakkattu chenduram – red oxide of consolidated zinc  
v Kaayakarpaaya chenduram  
v Sidigaiaya chenduram  
v Ayakattu chenduram    
  
 
 
 
 
MATERIALS AND METHODS 
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4. MATERIALS AND METHODS 
 
4.1. STANDARD OPERATIVE PROCEDURE1 
 
“Panchakkini chenduram” is a Siddha formulation which is mentioned in Siddha 
text Anuboga vaidya navaneetham, vol 1; page 92 Author- Hakkim Abdulla shayabu. 
 
The Ingredients of Panchakkini chenduram, 
 
1. Purified Arappodi (Iron)                                 - 35 gm(1palam) 
2. Purified Kaantham (Magnetic oxide of iron)    - 35 gm(1palam) 
3. Sangu Chunnam(Conch shell)           - 35gm(1palam) 
4. Purified Nellikkai Gandhagam (Sulphur)          - 35 gm(1palam) 
5. Purified Navacharam (Ammonium Chloride)    - 35 gm(1palam) 
 
Source of Collection: 
The drugs were purchased from reputed country raw drug shop, Paris corner in 
Chennai. 
 
Identification and Authentication of the drug: 
 
The identity and authenticity of the mineral drugs were confirmed by Dr.M.Suresh 
Gandhi, Department of Geology, University of Madras, Chennai.  
 
Purification of the ingredients:  
 
1. Arappodi (Iron) 
 
  The iron powder was immersed in lemon juice,vinegar,latex of country castor 
(Jatropha curcas) each for 3days. Then it was washed. 
 
2. Kaantham (Magnetic oxide of iron) 
 
The magnetic oxide of iron was soaked in lemon juice, sour old rice water 
fermentation and sour butter milk for three days in each. It was then dried in sun shineand 
washed. Thus its purified form was obtained. 
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3. Gandhagam (Sulphur)  
 
     Sulphur was placed in an iron spoon. A small quantity of cow’s butter was added. 
Then the spoon was heated till the butter melts. These mixtures were immersed in 
inclined position in cow’s milk. This procedure was repeated for 30 times to get purified 
sulphur. Each time fresh milk was used. 
 
 
4. Navacharam (Ammonium Chloride) 
 
It was dissolved in cow urine and filtered. The filtrate was boiled and insolated to 
get purified form. 
 
 
5. Sangu Chunnam (Conch shell) 
 
        The Conch was buried in lime stone, slaked and taken out after washing to get it 
purified.  
 
 
Method of preparation: 
 
Purified Kaantham and purified Arappodi were ground in a kalvam for 1hour, 
then purified Nellikkai Gandhagam was added and ground for 1 hour followed by 
purified Navacharam was added and ground for ½ hour, finally Sangu Chunnam was 
added and ground for 6 hour then collected in a porcelain plate and dried in sunlight for 6 
hours. 
 
 
Next day the mixture was placed in a sunlight from morning 10 am to evening 
5.00pm for fifteen days continuously. On 16th day, again it was ground in stone mortar for 
6hours and collected in a small mud pot covered with suitable lid, junction of the mud pot 
and lid was sealed with clay smeared cloth, allowed to dry in sun light then it was 
subjected into dhaniyaa pudam for 21 days. On 22nd day the pudam was opened and the 
chenduram was ground well and stored in an air tight container. 
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Labelling: 
 
Name   : Panchakkini Chenduram 
Colour   : Dark brown colour 
 Dose   : 3-4 Kundrimani (390-520mg) 
Adjuvant  : Puthina kudineer 
Date of Preparation  : 06.07.2016 
            Date of expiry  :  75 years 
 
Indication: 
 
        Kaamalai (liver diseases), Neerkattu (oliguria), Paandu (Anaemia).  
 
Therapeutic administration of drug 
 
Form of medicine  : Chenduram  
Route of administration  : Oral 
Dose     : 3-4 Kundrimani (390-520mg) 
Vehicle   : Puthina kudineer 
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INGREDIENTS OF THE DRUG 
 
GANDHAGAM     GANDHAGAM 
  (Before purification)                                   (After purification) 
 
 
  
 
 
 
 
 
 
  
  
 
NAVACHARAM    NAVACHARAM 
   (Before purification)                 (After purification) 
    
  
 
 
 
 
 
 
30 
 
KAANTHAM       KAANTHAM      
(Before purification)                (After purification) 
 
    
  
  
   
 
 
 
 
 
 
 
 
 
 
ARAPPODI  ARAPPODI 
          (Before purification)             (After purification) 
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SANGU   SANGU   
  (Before purification)            (After purification)   
 
 
 
 
 
 
 
 
 
PANCHAKKINI CHENDURAM 
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4.2 ANALYTICAL STUDY 
ANALYTICAL STUDIES OF PANCHAKKINI CHENDURAM 
 
Standardization of the drug brings the validation to be used as a medicine by 
subjecting the drug into many analysis and determining its quality and effectiveness. 
Standardization includes many studies such as organoleptic character, physicochemical 
characteristics studies and determination of phytochemical properties in order to assess 
the active principles present in the drug. Thus standardization brings the efficacy and 
potency of the drug. 
Standardization of the drug includes: 
 
Ø Pharmacognostic studies 
Ø Physicochemical analysis 
Ø Chemical analysis 
Ø FT-IR analysis 
Ø XRD analysis 
Ø SEM analysis 
Ø UV analysis 
 
4.2.1 PHARMACOGNOSTIC STUDIES OF PANCHAKKINI CHENDURAM 
 
 The pharmacognostical study was done at Regional research Institute of Unani 
Medicine, Royapuram, Chennai. 600013. 
 
4.2.1.1 ORGANOLEPTIC EVALUATION 
Colour 
  
  The Panchakkini Chenduram was taken into watch glasses and placed against white 
back ground in tube light. It was observed for its colour by naked eye. 
 
Odour 
  
 The Panchakkini Chenduram was smelled individually. The time interval among two 
smelling was kept 2 minutes to nullify the effect of previous smelling. 
 
Taste  
 Small amount of Panchakkini Chenduram was kept over the tip of the tongue. 
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4.2.2 PHYSICOCHEMICAL ANALYSIS 
 
 Physicochemical studies of the trial drug have been done according to the WHO 
guidelines. 
 
DETERMINATION OF ASH VALUES 
 
Total Ash 
 3g of the test drug was accurately weighed and incinerated in a crucible dish at a 
temperature not exceeding 450° C until it was free from carbon. It was then cooled and 
weighed. The % w/w of ash with reference to the air-dried powder was calculated. 
 
Water Soluble Ash 
 The total ash was obtained as the above method for preparation of total ash. The 
ash was boiled with 25ml of water for 5mins. The insoluble ashes were collected using 
filter paper. It was then washed with hot water and transferred to the silica crucible. It was 
then ignited for 15minutes at temperature not exceeding 450oC. For determination of 
weight of the water soluble ash the silica crucible and residue were weighed until constant 
weight was attained. The weight of the water soluble ash is determined by subtracting the 
weight of insoluble ash from the weight of total ash. 
 
MATERIALS AND METHODS 
 
Acid insoluble Ash 
The total ash was obtained as the above method for preparation of total ash. The 
ash was boiled for 5 minutes with 25ml 10% Hcl. The insoluble ashes were collected 
using filter paper and washed with hot water. It was then transferred to the silica crucible 
and ignited for 15 minutes at temperature not exceeding 450oC. The silica crucible and 
residue were weighed until constant weight is attained. 
 
DETERMINATION OF EXTRACTIVE VALUE 
 
Alcohol Soluble Extractive Value 
3g of test drug powder was weighed and macerated with 100ml of ethanol in a 
closed container for 24 hours. The resulting solution was shaken continuously for 6 hours. 
It was then allowed to stand and soak for 18 hours. The solution was filtered and 
evaporated of the filtrate in a flat bottomed shallow dish and dried at 105oC. Then the 
content was cooled and weighed. 
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Water soluble Extractive value 
 
3g of test drug powder was weighed and macerated with chloroform and water 
respectively, at 80oC for 24 hrs. The resulting solution was shaken continuously for 6 
hours and allowed to stand and soak for 24hrs then filtered. The solution from both 
chloroform and water respectively was filtered and evaporated of the filtrate in a flat 
bottomed shallow dish. It was dried at 105oC then cooled and weighed. 
 
DETERMINATION OF LOSS ON DRYING AT 105°C 
The powdered drug was taken and dried in the oven at 105°C to constant weight. 
The result was noted. 
 
4.2.3 CHEMICAL ANALYSIS OF PANCHAKKINI CHENDURAM 
 
The chemical analysis of “Panchakkini chenduram”was carried out in Bio 
chemistry lab, National Institute of Siddha. 
 
S.No EXPERIMENT OBSERVATION INFERENCE 
1.  Physical Appearance of extract Dark  brown  in colour  
2. Test for Silicate 
500mg of the sample medicine was 
shaken well with distilled water. 
Sparingly soluble 
 
 
Presence of 
Silicate 
 
 3. Action of Heat: 
 500mg of the sample medicine was 
taken in a dry test tube and heated 
gently at first and then strong. 
No White fumes 
evolved. 
No brown fumes 
evolved. 
Absence of  
Carbonate 
Absence of Nitrate. 
 
4. Flame Test: 
500mg of the sample medicine was 
made into a paste with con. HCl in a 
watch glass and introduced into non-
luminous part of the Bunsen flame. 
No bluish green flame 
 
Absence  of copper 
 
 
5. Ash Test: 
A filter paper was soaked into a 
mixture of extract and dil. cobalt 
nitrate solution and introduced into the 
Bunsen flame and ignited. 
 
Appearance of yellow 
colour flame 
 
 
 
Absense of sodium 
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Preparation of Extract: 
5gm of sample medicine was taken in a 250ml clean beaker and added with 50ml 
of distilled water. Then it was boiled well for about 10 minutes. Then it was cooled and 
filtered in a 100ml volumetric flask and made up to 100ml with distilled water. This 
preparation was used for the qualitative analysis of acidic/basic radicals and biochemical 
constituents in it. 
S.No EXPERIMENT OBSERVATION INFERENCE 
 I. Test For Acid Radicals   
1. Test For Sulphate: 
2ml of the above prepared extract was taken 
in a test tube to this added 2ml of 4% dil. 
ammonium oxalate solution 
No cloudy 
appearance 
 
Absence of 
sulphate 
2. Test For Chloride: 
2ml of the above prepared extracts was 
added with 2ml of dil. HCl is added until the 
effervescence ceases off. 
No cloudy 
appearance was 
formed 
Absence of 
Chloride 
3 Test For Phosphate  
2ml of the extract were treated with 2ml of 
dil. ammonium molybdate solution and 2ml 
of con.HN03 
Cloudy yellow 
appearance present 
Presence of 
phosphate 
4 Test For Carbonate: 
2ml of the extract was treated with 2ml             
dil. magnesium sulphate solution 
No cloudy 
appearance. 
Absence of  
carbonate 
5. Test For Nitrate: 
1gm of the sample medicine was heated with 
copper turning and concentrated H2S04 and 
viewed the test tube vertically down. 
No Brown gas was 
evolved 
 
Absence of nitrate 
6. Test For Sulphide: 
1gm of the sample medicine was treated with 
2ml of con. HCl 
No rotten egg 
smelling gas was 
evolved 
Absence of 
sulphide 
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7. Test For Fluoride & Oxalate: 
2ml of extract was added with 2ml of dil. 
Acetic acid and 2ml dil.calcium chloride 
solution and heated. 
No cloudy 
appearance. 
 
Absence of 
fluoride and 
oxalate 
8. 
 
Test For Nitrite: 
3drops of the extract was placed on a filter 
paper, on that-2 drops of dil. acetic acid and 
2 drops of dil.Benzidine solution is placed. 
No characteristic 
changes noted. Absence of nitrite 
9. Test For Borate: 
50mg of the sample medicine was made into 
paste by using dil. Sulphuric acid and 
alcohol (95%) and introduced into the blue 
flame. 
No appearance  
bluish green 
colour. 
Absence  of 
borate 
 
II. Test For Basic Radicals 
1. Test For Lead: 
2ml of the extract was added with 2ml of dil. 
potassium iodine solution. 
No Yellow 
precipitate was 
obtained 
 
Absence of lead 
2. Test For Copper: 
One pinch (25mg) of sample medicine was 
made into paste with con. HCl in a watch 
glass and introduced into the non-luminuous 
part of the flame. 
No blue colour 
precipitate 
Absence of    
copper 
 
3. Test For Aluminium: 
To the 2ml of extract dil. Sodium hydroxide 
was added in 5 drops to excess. 
No yellow colour 
appeared 
 
Absence of    
Aluminium. 
 
4. Test For Iron:To the 2ml of extract add 2ml 
of dil. Ammonium solution 
b. To the 2ml of extract 2ml  thiocyanate 
solution and 2ml  of con HNo3 is added 
Red colour 
appeared 
Presence of 
Iron 
5. Test For Zinc:  
To 2ml of the extract dil. Sodium hydroxide 
solution was added in 5 drops to excess and 
dil. Ammonium chloride is added.  
No White 
precipitate was 
formed 
Absence of 
Zinc 
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6. Test For Calcium:  
2ml of the extract was added with 2ml of 4% 
dil. Ammonium oxalate solution  
No Cloudy 
appearance and 
white precipitate 
was formed was is 
was formed 
Absence of 
calcium 
7. Test For Magnesium:  
To 2ml of extract dil. Sodium hydroxide 
solution was added in drops to excess. 
White precipitate  
was obtained 
Presence of 
magnesium 
8. Test For Ammonium: 
To 2ml of extract 1 ml of Nessler's reagent 
and excess of dil. Sodium hydroxide solution 
are added. 
No  Brown colour 
appeared 
Absence  of 
ammonium 
9. 
 
Test For Potassium: 
A pinch (25mg) of sample medicine was 
treated  with 2ml of dil. Sodium nitrite 
solution and then treated with 2ml of dil. 
Cobalt nitrate in 30% dil. Glacial acetic acid. 
 
No Yellow 
precipitate  was 
obtained 
 
Absence  of 
potassium 
10. Test For Sodium: 
 2 pinches (50mg) of the sample medicine is 
made into paste by using HCl and introduced 
into the blue flame of Bunsen burner. 
No yellow colour 
flame evolved. 
 
 
Absence of 
sodium 
11. Test For Mercury:  
2ml of the extract was treated with 2ml of 
dil. Sodium hydroxide solution.  
No Yellow 
precipitate was 
obtained 
 
Absence of 
Mercury 
 
12. Test For Arsenic:  
   2ml of the extract was treated with 2ml of 
dil. Sodium hydroxide solution. 
No  Brownish red 
precipitate  was 
obtained 
Absence of 
arsenic 
III. Miscellaneous 
1.
  
Test For Starch: 
2ml of extract was treated with weak dil.Iodine 
solution  
No Blue 
colour developed 
Absence of starch 
2.
  
Test For Reducing Sugar: 
 5ml of Benedict's qualitative solution was 
taken in a test tube and allowed to boil for2 
minutes and added 8 to 10 drops of the extract 
and again boil it for 2 minutes. The colour 
changes were noted. 
 
No Brick red 
colour was  
developed 
 
Absence of  
reducing sugar 
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3. Test For The Alkaloids: 
a) 2ml of the extract was treated with 2ml of 
dil. Potassium Iodide solution. 
b)  2ml of the extract was treated with 2ml of 
dil. Picric acid. 
c)  2ml of the extract was treated with 2ml of 
dil.Phosphotungstic acid. 
No red colour 
developed 
Absence 
of Alkaloid 
 
 
4.
  
Test For Tannic Acid:  
2ml of extract was treated with 2ml of dil. 
Ferric chloride solution  
No Blue-black 
precipitate  was 
obtained 
Absence of 
Tannic acid 
5. 
  
Test For Unsaturated Compound: 
To the 2ml of extract 2ml of dil.Potassium 
permanganate solution is added.  
Potassium 
permanganate is 
not decolourised 
Absence of 
unsaturated 
compound 
6.
  
Test For Amino Acid: 
2 drops of the extract was placed on a filter 
paper and dried well. 20ml of Burette reagent 
is added. 
No violet colour 
 
Absence of amino 
Acid 
7. Test For Type of Compound: 
2ml of the extract was treated with 2 ml of dil. 
Ferric chloride solution.  
 
No green and red 
colour 
 
Absence of 
quinolepinephrine 
pyrocatecho anti 
pyrine, Aliphatic 
amino acid and 
meconic acid.   
  No Violet colour 
developed 
 
Apomorphine 
salicylate and 
Resorcinol are 
absent 
  No Blue colour 
developed 
Morphine, Phenol 
cresol and 
hydroquinone are 
present. 
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ANALYTICAL STUDY 
 
4.2.4 FOURIER TRANSFORM  INFRARED (FTIR):  
 
The Infrared spectrum originates from the vibrational motion of the molecule. The 
vibrational frequencies are a kind of finger print of the compounds. This property is used 
for characterization of organic, inorganic and biological compounds. The band intensities 
are proportional to the concentration of the compound and hence qualitative estimations 
are possible. The IR spectroscopy is also carried out by using Fourier transform 
technique. 
 
Description: 
 
The Perkin Elmer Spectrum FTIR instrument consists of globar and mercury vapour lamp 
as sources, an interferometer chamber comprising of KBr and mylar beam splitters 
followed by a sample chamber and detector. Entire region of 400-4500 cm-1 is covered 
by this instrument. The spectrometer works under purged conditions. Solid samples are 
dispersed in KBr or polyethylene pellets depending on the region of interest. This 
instrument has a typical resolution of 1.0 cm-1.Signal averaging, signal enhancement, 
base line correction and other spectral manipulations are possible.  
 
         The interference pattern obtained from a two beam interferometer as the path 
difference between the two beams is altered, when Fourier transformed, gives rise to the 
spectrum. The transformation of the interferogram into spectrum is carried out 
mathematically with a dedicated on-line computer.  
 
Model    :  Spectrum 1 FTIR spectrometer  
Scan range   :  MIR 450-4500 cm-1  
Resolution   :  1.0 cm-1 
Sample required  :  50 mg solid or liquid. 58  
 
Sample preparation: 
 
Solid  :  KBr or Nujol mull method  
Liquid  :  CsI / T1Br Cells 
Gas   : Gas cells 
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KBr method : 
 
              The sample was grounded using an agate motor and pestle to give a very fine 
powder. The finely powder sample was mixed with about 100 mg dried potassium 
bromide salt. The mixture was then pressed under hydraulic press using a die to yield a 
transparent disc (measure about 13 mm diameter and 0.3 mm in thickness) through which 
the beam of spectrometer passed. 
 
Applications: 
 
            Infrared spectrum is useful in identifying the functional groups like –OH, -CN, -
NH2, etc. Also quntitative estimation is possible in certain cases for chemical, 
pharmaceuticals, petroleum products, etc. Resins from industries, water and rubber 
samples can be analysed. Blood and food materials can also be analysed32. 
 
4.2.5 X-RAY DIFFRACTION (POWDER XRD): 
 
PXRD is a compact advanced instrument. When X-rays falls over a crystal, it 
diffracts in a pattern characteristic to its structure. A diffraction pattern plots Intensity 
against the angle of detector, 2 . Diffraction occurs when light is scattered by a periodic 
array with the range of order, producing constructive interference at specific angles. The 
pattern contains information about the atomic arrangement in crystal. Amorphous 
materials like glass do not have periodic array with long range order, so they do not 
produce any significant diffraction pattern.  
Sample required: 25gm to be submitted.  
 
Sample preparation:  
 
Ø Approximately 1gm was kept as a reference, 5gm was taken for sample 
preparation and the remainder was used for preparation of decalcified, fractioned 
2-20µ and less than 2µ samples.  
Ø Sample was disaggregated in waring blenders with 250ml hot distilled water until 
no lumps of sediment are visible.  
Ø The sample was centrifuged and the wash-water was decanted.  
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Ø Then the sample was allowed to dry and disaggregated manually with a mortar 
and pestle. 
Ø Coarse grained sample was reduced to silt size.  
Ø Then it was placed in mortar and pestle grinders and heat generated grinding done 
under butanol for 2 hours.  
Ø After grinding, butanol was evaporated under heat lamps.   
Ø The ground sample was treated with trihexylamine acetate 
Ø Then the sample was pressed into sample holder. 
 
Benefits: 
It serves a major role in all stage of drug development, testing and production. It is 
an essential part of analytical research and development, quality control of the active 
ingredients, excipients and final products. It helps in elucidation of the relevant 
polymorphic and pseudo-polymorphic forms in pharmaceutical development.  
 
Advantage:  
 
The PXRD analysis of crystalline compounds gives a diffraction pattern 
consisting of a well defined, narrow, sharp and significany peak while amorphous 
materials do not give clear peaks rather the pattern has noise signals, smeared peak or it 
can have some short order bumps. 
 
 Powder XRD is used to determine the crystallinity by comparing the integrated 
intensity of the background pattern to that of the sharp peaks33. 
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4.2.6 SCANNING ELECTRON MICROSCOPE (HR-SEM):  
 
 A SEM is essentially a high magnification microscope, which uses a focused 
scanned electron beam to produce images of the sample, both top – down, and with the 
necessary preparation and sample preparation, cross-section. The Quanta 200 FEG 
scanning electron microscope (SEM) is a versatile high resolution scanning electron 
microscope with three modes of operation namely,   High vaccum (HV) mode for metallic 
(electrically conducting) sample,  
 
 Low vaccum (LV) modes for insulating, ceramic, polymeric (electrically 
insulating)  
 
Environment scanning electron microscope (ESEM) for biological samples 
respectively. Apart from giving the high resolution surface morphological images, the 
Quanta 200 FEG also has the analytical capabilities such as detecting the presence of 
elements down to boron on any solid conducting materials through the energy dispersive 
X-ray spectrometry (EDX) providing crystalline information from the few nanometre 
depth of the material surface via electron back scattered detection (BSD) system attached 
with microscope and advanced technological PBS (WDS) for elemental analysis. 
 
Resolution  : 1.2 nm gold particle separation on a carbon substrate 
Magnification  :  From a minimum of 12X to greater than 1, 00,000 X 
Application  : To evaluate grain size, particle size distributions, material  
homogeneity and inter metallic distributions. 
 
Sample required: 
 
          Any dimension (Height or Diameter) less than 10 mm. The ideal shape of a sample 
was that of a button on a shirt. However, the other sizes can also be accommodated only 
after the discussion with the system operator. 
 
          If the sample was not electrically conducting, it will require silver or gold coating. 
If the sample was a powder, make a normal button size pellet of the sample. If the sample 
was insulator (or) polymeric (or) electrically non-conducting it needs to be coated with 
carbon.  
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Calculation of the particle size: 
 
        The horizontal line in the right corner of the micrograph corresponds to micro in 
length would be given. A comparison could be made between the length of the particles 
visible in the micrograph with this line and the length of the particles was calculated. 
 
Sample preparation: 
 
            Sample preparation can be minimal or elaborate for SEM analysis, depending on 
the nature of the samples and the data required. Minimal preparation includes acquisition 
of a sample that will fit into the SEM chamber and some accommodation to prevent garge 
build-up on electrically insulating samples. Most electrically insulating samples are 
coated with a thin layer of conducting material, commonly carbon, gold, or some other 
metal or alloy. The choice of material for conductive coatings depends on the data to be 
acquired. Carbon is most desirable if elemental analysis is a priority, while metal coatings 
are most effective for high resolution electron imaging applications34. 
 
4.2.7 ULTRAVIOLET – VISIBLE SPECTROSCOPY 
 
UV spectroscopy is an important tool in analytical chemistry. The other name of 
UV (Ultra-Violet) spectroscopy is Electronic spectroscopy as it involves the promotion of 
the electrons from the ground state to the higher energy or excited state. 
Introduction to UV Spectroscopy 
 
UV spectroscopy is type of absorption spectroscopy in which light of ultra-violet 
region (200-400 nm.) is absorbed by the molecule. Absorption of the ultra-violet 
radiations results in the excitation of the electrons from the ground state to higher energy 
state. 
 
Principle of UV Spectroscopy 
 
UV spectroscopy obeys the Beer-Lambert law, which states that: when a beam of 
monochromatic light is passed through a solution of an absorbing substance, the rate of 
decrease of intensity of radiation with thickness of the absorbing solution is proportional 
to the incident radiation as well as the concentration of the solution. 
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Procedure 
 
       Monochromators generally composed of prisms and slits. The most of the 
spectrophotometers are double beam spectrophotometers. The radiation emitted from the 
primary source is dispersed with the help of rotating prisms. The various wave lengths of 
the light source which are separated by the prism are then selected by the slits such the 
rotation of the prism results in a series of continuously increasing wave length to pass 
through the slits for recording purpose. The beam selected by the slit is monochromatic 
and further divided into two beams with the help of another prism. 
 
Uses  
Identification of an unknown compound 
 
  An unknown compound can be identified with the help of UV spectroscopy. The 
spectrum of unknown compound is compared with the spectrum of a reference compound 
and if both the spectrums coincide then it confirms the identification of the unknown 
substance. 
 
Determination of the purity of a substance 
 
 Purity of a substance can also be determined with the help of UV spectroscopy. 
The absorption of the sample solution is compared with the absorption of the reference 
solution. The intensity of the absorption can be used for the relative calculation of the 
purity of the sample substance35. 
 
 
 
 
 
 
 
 
 
 
 
 
TOXICOLOGICAL STUDIES 
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5.  TOXICITY STUDIES 
ACUTE ORAL TOXICITY STUDY OF PANCHAKKINI CHENDURAM 
                                (OECD GUIDELINE – 423)     
 
Introduction: 
 
v The acute toxic class method is a stepwise procedure with the use of 3 animals of 
a single sex per step. 
v Depending on the mortality and/or the moribund status of the animals, on average 
2-4 steps may be necessary to allow judgment on the acute toxicity of the test 
substance.  
v This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods.  
v The acute toxic class method is based on biometric evaluations with fixed doses, 
adequately separated to enable a substance to be ranked for classification purposes 
and hazard assessment.  
v In principle, the method is not intended to allow the calculation of a precise LD50, 
but does allow for the determination of defined exposure ranges where lethality is 
expected since death of a proportion of the animals is still the major endpoint of 
this test.  
v The method allows for the determination of an LD50 value only when at least two 
doses result in mortality higher than 0% and lower than 100%.  
v The use of a selection of pre-defined doses, regardless of test substance, with   
classification explicitly tied to number of animals observed in different states 
improves the opportunity for laboratory to laboratory reporting consistency and 
repeatability.  
 
Principle of the Test:  
 
It is the principle of the test that based on a stepwise procedure with the use of a 
minimum number of animals per step, sufficient information is obtained on the acute 
toxicity of the test substance to enable its classification. The substance is administered 
orally to a group of experimental animals at one of the defined doses. The substance is 
tested using a stepwise procedure, each step using three animals of a single sex. Absence 
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or presence of compound-related mortality of the animals dosed at one step will 
determine the next step, i.e. 
 
− No further testing is needed 
− Dosing of three additional animals, with the same dose  
− Dosing of three additional animals at the next higher or the next lower dose 
level. The method will enable a judgment with respect to classifying the test substance to 
one of a series of toxicity classes. 
 
Methodology: 
Selection of Animal Species  
 
 The preferred rodent species is the Wistar albino rat, although other rodent species 
may be used. Healthy young adult animals are commonly used laboratory strains should 
be employed. Females should be nulliparous and non-pregnant. Each animal, at the 
commencement of its dosing, should be between 6 to 8 weeks old and the weight (150-
200gm) should fall in an interval within±20 % of the mean weight of any previously 
dosed animals.  
 
Housing and Feeding Conditions 
 
The temperature in the experimental animal room should be 22ºC+3ºC.  Although 
the relative humidity should be at least 30% and preferably not exceed 70% other than 
during room cleaning the aim should be 50-60%. Lighting should be artificial, the 
sequence being 12 hours light, 12 hours dark. For feeding, conventional laboratory diets 
may be used with an unlimited supply of drinking water. Animals may be group-caged by 
dose, but the number of animals per cage must not interfere with clear observations of 
each animal. 
 
Preparation of animals:   
  
The animals were randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization to 
the laboratory conditions 
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Test Animals and Test Conditions:  
 
Sexually mature Female Wistar albino rats (150-200gm) were obtained from 
TANUVAS, Madhavaram, Chennai. All the animals were kept under standard 
environmental condition (22±3°C).  The animals had free access to water and standard 
pellet diet (Sai meera foods, Bangalore) 
 
Preparation of animals:   
 
The animals were randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization to 
the laboratory conditions 
 
Preparation for Acute Toxicity Studies 
 
 Rats were deprived of food overnight (but not water 16-18 h) prior to 
administration of the, Panchakkini Chenduram. 
 
The principles of laboratory animal care were followed and the Institutional 
Animal Ethical Committee approved the use of the animals and the study design. 
 
IAEC approved  Number: IAEC/XLIX/16/CLBMCP/2016 
 
Test Substance  :  PANCHAKKINI CHENDURAM 
Animal Source  :   TANUVAS, Madhavaram, Chennai.   
Animals   :   Wister Albino Rats (Female-3+3) 
Age    :   6-8 weeks 
Body Weight    :   150-200gm. 
Acclimatization  :   Seven days prior to dosing. 
Veterinary examination :   Prior and at the end of the acclimatization period. 
Identification of animals :   By cage number, animal number and individual   
                marking by using Picric acid. 
Number of animals             :   3 Female/group,  
Route of administration       :   Oral  
Diet    :   Pellet feed supplied by Sai meera foods Pvt Ltd,  
Bangalore 
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Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages  
                provided with bedding of husk. 
Housing temperature : between 22ºC + 3ºC.   
Relative humidity  :  between 30% and 70%, 
Air changes    :   10 to 15 per hour and  
Dark and light cycle   :  12:12 hours. 
Duration of the study :  14 Days 
 
Administration of Doses:  
 
 Panchakkini Chenduram was suspended in water and administered to the groups 
of Wistar albino rats in a single oral dose by gavage using a feeding needle. The control 
group received an equal volume of the vehicle. Animals were fasted 12 hours prior to 
dosing. Following the period of fasting, the animals were weighed and then the test 
substance was administered. Three Female animals are used for each group. The dose 
level of 5, 50, 300 and 2000 mg/kg body weight was administered stepwise. After the 
substance has been administered, food was withheld for a further 3-4 hours. The principle 
of laboratory animal care was followed. Observations were made and recorded 
systematically and continuously as per the guideline after substance administration. The 
visual observations included skin changes, mobility, aggressively, sensitivity to sound 
and pain, as well as respiratory movements. Finally, the number of survivors was noted 
after 24 hrs and these animals were then monitered for a further 14 days and observations 
made daily. The toxicological effect was assessed on the basis of mortality. 
 
Observations:  
 
Animals were observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the first 
4 hours, and daily thereafter, for a total of 14 days, except where they need to be removed 
from the study and humanely killed for animal welfare reasons or are found dead. It 
should be determined by the toxic reactions, time of onset and length of recovery period, 
and may thus be extended when considered necessary. The times at which signs of 
toxicity appear and disappear are important, especially if there is a tendency for toxic 
signs to be delayed. All observations are systematically recorded with individual records 
being maintained for each animal. 
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Observations include changes in skin and fur, eyes and mucous membranes, and 
also respiratory, circulatory, autonomic and central nervous systems, and somatomotor 
activity and behavior pattern. Attention was directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. The principles and criteria 
summarized in the Humane End points Guidance Document taken into consideration. 
Animals found in a moribund condition and animals showing severe pain or enduring 
signs of severe distress was humanly killed. When animals are killed for human reasons 
or found dead, the time of death was recorded. 
 
5.1  Acute oral toxicity study of Panchakkini Chenduram 
      Dose finding experiment and its behavioral Signs of acute oral Toxicity 
      Observation done: 
SL Group CONTROL Observation SL 
Group 
TEST GROUP 
Observation 
1 Body weight Normal 1 Body weight Normally 
increased 
2 Assessments of 
posture 
Normal 2 Assessments 
of posture 
Normal 
3 Signs of 
Convulsion 
Limb paralysis 
Normal 3 Signs of 
Convulsion 
Limb paralysis 
Absence of 
sign (-) 
4 Body tone Normal 4 Body tone Normal 
5 Lacrimation Normal 5 Lacrimation Absence 
6 Salivation Normal 6 Salivation Absence 
7 Change in skin 
color 
No 
significant 
Color change 
7 Change in skin 
Color 
No 
significant 
color Change 
8 Piloerection Normal 8 Piloerection Normal 
9 Defecation Normal 
 
9 Defecation Normal 
 
10 Sensitivity 
response 
Normal 10 Sensitivity 
Response 
Normal 
11 Locomotion Normal 11 Locomotion Normal 
12 Muscle gripness Normal 12 Muscle Gripness Normal 
13 Rearing Mild 13 Rearing   Mild 
14 Urination Normal 14 Urination Normal 
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Behaviour: 
 
 The animals will be observed closely for behaviour in the first four hours which  
includes abnormal gait, aggressiveness, exophthalmos, ptosis, akinesia, catalepsy, 
convolusion, excitation, head twitches, lacrimation, loss of corneal reflex, loss of traction, 
piloerection  reactivity of touch, salivation, scratching, sedation, chewing,  head 
movements, sniffing, straub, tremor and writhes, diarrhea, leathery, sleep and coma.  
 
Body Weight:  
Individual weight of animals was determined before the test substance was 
administered and weights will be recorded at day 1, 7, and 14 of the study. Weight 
changes were calculated and recorded. At the end of the test, surviving animals were 
weighed and humanly killed. 
 
Food and water Consumption: 
   
Food and water consumed per animal was calculated for control and the treated 
dose groups.  
 
Mortality: 
 
Animals were observed for mortality throughout the entire period. 
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5.2 REPEATED DOSE 28-DAY ORAL TOXICITY (407) STUDY OF 
PANCHAKKINI CHENDURAM 
 
Test Substance  :  PANCHAKKINI CHENDURAM 
Animal Source  :  TANUVAS, Madhavaram, Chennai.   
Animals   :  Wistar Albino Rats (Male -24, and Female-24) 
Age    :  6-8 weeks 
Body Weight               :  150-200gm. 
Acclimatization  :  Seven days prior to dose. 
Veterinary examination :  Prior and at the end of the acclimatization period. 
Identification of animals :   By cage number, animal number   and    individual  
   marking by using Picric acid 
 
Diet    :  Pellet feed supplied by Sai Meera Foods Pvt Ltd,    
                Bangalore 
Water    :  Aqua guard portable water in polypropylene bottles. 
Housing & Environment :  The animals were housed in Polypropylene cages  
     provided with bedding of husk. 
Housing temperature :   between 22ºC±3ºC.   
Relative humidity  :   between 30% and 70%, 
Air changes    :  10 to 15 per hour  
Dark and light cycle   :  12:12 hours. 
Duration of the study :  28 Days.  
 
 
PC – PANCHAKKINI CHENDURAM 
 
Groups No of Rats 
Group I Vehicle control (Water) 12 (6male,6 female) 
Group II PC- low dose  2.5mg 12 (6male,6 female) 
Group III PC- Mid dose 5mg 12  (6male,6female) 
Group IV PC- High dose 10mg 12 (6male,6female) 
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Methodology 
Randomization, Numbering and Grouping of Animals: 
 
48 Wistar Albino Rats (24M + 24F) were selected and divided into 4 groups. Each 
group consist of 12 animals (Male -6, and Female-6). First group treated as a control and 
other three group were treated with test drug (low, mid, high) for 28 days. Animals were 
allowed acclimatization period of 7 days to laboratory conditions prior to the initiation of 
treatment. Each animal was marked with picric acid. The females were nulliparous and 
non-pregnant. 
 
Justification for Dose Selection: 
 
         As per OECD guideline three dose levels were selected for the study. They are low 
dose, mid dose, high dose. X is calculated by multiplying the therapeutic dose (600 mg) 
and the body surface area of the rat (0.018). Low dose is 2.5mg/kg, Mid dose is 5mg/kg, 
High dose is 10mg / kg. 
Preparation and Administration of Dose: 
 
PANCHAKKINI CHENDURAM suspended in with Puthina kudineer. It was 
administered to animals at the dose levels of Low, Mid, High. The test substance 
suspensions were freshly prepared every two days once for 28 days. The control animals 
were administered vehicle only. The drug was administered orally by using oral gavage 
once daily for 28 consecutive days. 
 
Observations: 
Experimental animals were kept under observation throughout the course of study 
for the following: 
Body Weight: 
 
 Weight of each rat was recorded on day 1, at weekly intervals throughout the 
course of study. 
 
Food and water Consumption: 
  
Food and water consumed per animal was calculated for control and the treated 
dose groups.  
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Clinical signs:  
 
All animals were observed daily for clinical signs. The time of onset, intensity and 
duration of these symptoms, if any, were recorded. 
 
Mortality: 
All animals were observed twice daily for mortality during entire course of study. 
 
Necropsy: 
 
All the animals were sacrificed by excessive anesthesia on day 29. Necropsy of all 
animals was carried out. 
 
TERMINAL STUDIES 
Laboratory Investigations: 
 
Following laboratory investigations were carried out on day 29 in animals fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for Hematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
 
Haematological Investigations: 
 
Haematological parameters were determined using Haematology analyzer.  
 
Biochemical Investigations:  
              Biochemical parameters were determined using auto-analyzer. 
 
Histopathology:  
              Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group than 
the low, then the mid dose group will also be examined. Organs will be collected from all 
animals and preserved in 10% buffered neutral formalin for 24 h and washed in running 
water for 24 h.  The organ sliced 5 or 6µm sections and were dehydrated in an auto 
technicon and then cleared in benzene to remove absolute alcohol. Embedding was done 
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by passing the cleared samples through three cups containing molten paraffin at 50°C and 
then in a cubical block of paraffin made by the “L” moulds. It was followed by 
microtome and the slides were stained with Haematoxylin-eosin red. 
 
Statistical analysis:  
Findings such as body weight changes, water and food consumption, hematology 
and blood chemistry were subjected to One-way ANOVA followed by dunnett’s test 
using a computer software programme – Graph pad version 7. All data were summarized 
in tabular form, (Table-13 to 19) 
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5.3  REPEATED DOSE 90-DAY ORAL TOXICITY STUDY OF PANCHAKKINI 
CHENDURAM (OECD GUIDELINE - 408) 
 
Test Substance  :    PANCHAKKINI CHENDURAM 
Animal Source  :    TANUVAS,Madhavaram, Chennai.   
Animals   :    Wistar Albino Rats (Male -40, and Female-40) 
Age    :    6-8 weeks 
Body Weight               :    150-200gm. 
Acclimatization  :    Seven days prior to dosing. 
Veterinary examination :    Prior and at the end of the acclimatization period. 
Identification of animals :    By cage number, animal number   and    individual  
   marking by using picric acid.      
Diet    :    Pellet feed supplied by Sai meera foods Pvt Ltd,       
                           Bangalore 
Water    :    Aqua guard portable water in polypropylene bottles. 
Housing & Environment :    The animals were housed in Polypropylene cages  
                provided with bedding of husk. 
Housing temperature :     between 22ºC + 3ºC.   
Relative humidity  :     between 30% and 70%, 
Air changes    :    10 to 15 per hour  
Dark and light cycle   :    12:12 hours. 
Duration of the study :    90 Days. 
 
 
PC- PANCHAKKINI CHENDURAM 
 
 
 
Groups No of Rats 
Group I  Vehicle control  20 (10male, 10female) 
Group II PC- low dose 2.5mg 20 (10male, 10female) 
Group III PC - Mid dose 5mg 20 (10male, 10female) 
Group IV PC - High dose 10 mg 20  (10male,10female) 
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Methodology 
Randomization, Numbering and Grouping of Animals: 
 
80 Wistar Albino Rats (40M + 40F) were selected and divided into 4 groups. Each 
group consists of 20 animals (Male -10 and Female-10). First group treated as a control 
and other three groups were treated with test drug (low, mid, high) for 90 days. Animals 
were allowed acclimatization period of 7 days to laboratory conditions prior to the 
initiation of treatment. Each animal was marked with picric acid. The females were 
nulliparous and non-pregnant. 
 
Justification for Dose Selection: 
        
As per OECD guideline three dose levels were selected for the study. They are 
low dose, mid dose, high dose. X is calculated from the Therapeutic dose (600mg) and 
the body surface area of the rat (0.018).  Low dose is 2.5mg/kg, Mid dose is 5mg/kg, 
High dose is 10 mg/kg. 
 
Preparation and Administration of Dose: 
 
PANCHAKKINI CHENDURAM was administered to animals at the dose levels 
of low, mid and high dose. The control animals were administered vehicle (Puthina 
kudineer) only. The drug was administered orally by using oral gavage once daily for 90 
consecutive days. 
 
Observations:  
Experimental animals were kept under observation throughout the course of Study 
for the following: 
Body Weight: 
 
Weight of each rat was recorded on day 1,15,30,45,60,75,90, at biweekly intervals 
throughout the course of study. 
 
Food and water Consumption: 
Food and water consumed per animal was calculated for control and the treated 
dose groups. 
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Clinical signs:  
 
All animals were observed daily for clinical signs. The time of onset, intensity and 
duration of these symptoms, if any, were recorded. 
 
Mortality: 
 
All animals were observed twice daily for mortality during entire course of   
study. 
 
Necropsy: 
 
All the animals were sacrificed by excessive anesthesia on day 91. Necropsy of all 
animals was carried out. 
 
Laboratory Investigations: 
 
Following laboratory investigations were carried out on day 91 in animals fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for Hematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
 
Haematological Investigations: 
 
 Haematological parameters were determined using Haematology analyzer.  
 
Biochemical Investigations:  
           
     Biochemical parameters were determined using auto-analyzer 
 
Histopathology:  
           
     Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group than 
the low, then the mid dose group will also be examined. Organs will be collected from all 
animals and preserved in 10% buffered neutral formalin for 24 h and washed in running 
water for 24 h.  The organ sliced 5 or 6µm sections and were dehydrated in an auto 
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technicon and then cleared in benzene to remove absolute alcohol. Embedding was done 
by passing the cleared samples through three cups containing molten paraffin at 50°C and 
then in a cubical block of paraffin made by the “L” moulds. It was followed by 
microtome and the slides were stained with Haematoxylin-eosin. 
 
Statistical analysis:  
 
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, hematology and blood chemistry were subjected to One-way ANOVA 
followed by dunnett’s test using a statistics software Graph Pad version 7. All data were 
summarized in tabular form (Table 20-25) 
 
 
 
 
 
 
 
 
 
 
 
 
PHARMACOLOGICAL STUDIES 
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6. PHARMOLOGICAL STUDIES 
6.1 HEPATOPROTECTIVE ACTIVITY OF PANCHAKKINI CHENDURAM 
Aim 
 To study the Hepatoprotective of Panchakkini Chenduram in Wistar albino rats by 
paracetamol induced hepatotoxicity method. 
 
Selection of animals: 
 
Healthy either sex of Wistar albino rats (150-200g) were used for this study with 
the approval of the institutional animal ethics committee and obtained from the animals 
laboratory. 
 
IAEC approved Number: IAEC/XLIX/16/CLBMCP/2016 
 
        The animals kept in plastic cages and maintained at22ºC + 30ºC. All the rats were 
housed individually with free access to food, water and libitum. They were feed with 
standard diet and kept in well ventilated animal house they also maintained with 
alternative dark-light cycle of 12hours throughout the studies. Rats were allowed an 
acclimatization period of 7days before actual experiments. The rats were closely observed 
for any infection and if they show signs of infection they were excluded from the study. 
The animal experiment was performed with accordance legislation on welfare.   
 
Experimental design15 
 
    The paracetamol was diluted with sucrose solution (40% w/v). (1:1) before 
administration. The animals were divided into 5 groups of 6 each. The animals were then 
subjected to either one of the following treatments for 9 days. 
 
Group 1 :  Distilled water (1ml/kg, po) 
Group 2 :  Distilled water for 9 days + Paracetamol (1g/kg, po) on ninth day 
Group 3 :  Silymarin (100mg/ kg, po) for 9 days + Paracetamol (1g/kg, po) on ninth day 
Group 4 :  PC (5 mg/kg/day, po) for 9 days+ Paracetamol (1g/kg, po) on ninth day 
Group 5 :  PC (10mg/kg/day, po) for 9 days+ Paracetamol (1g/kg, po) on ninth day 
 
PC -PANCHAKKINI CHENDURAM 
Food was withdrawn 12hr before paracetamol administration to enhance the acute 
liver damage in animals of group 2, 3, 4 and 5. The animals were sacrificed 48hr after the 
administration of paracetamol. The blood samples were collected. 
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Blood sample collection and analysis 
 
Blood samples for haematological analysis were collected from all the rats 
through the retro-orbital venous plexus under ether-induced anaesthesia, into heparinized 
tubes while the sample for serum biochemistry was collected into plain tubes. From the 
blood samples collected, packed cell volume (PCV) was determined by micro haematocrit 
method, haemoglobin concentration(Hb) by cyanmethaemoglobin method while the red 
blood cells (RBC) and white blood cells (WBC) were counted using haemocytometer. 
Means corpuscular volume (MCV), means corpuscular haemoglobin (MCH) and mean 
corpuscular haemoglobin concentration (MCHC)were calculated from the values of  
PCV, Hb, and RBC count as described by jain ,(1986)16. Erythrocyte osmotic fragility 
were determined according to the method described by oyewale,(1992)17by diluting 
0.02ml of blood in test tubes containing 0-0.9% NaCl in phosphate buffer at pHof 7.4. 
The tubes were gently mixed and incubated at room temperature (29ºC) for 30 minutes, 
then centrifuged at 3500rev/min for 10 minutes. The supernatant were decanted and the 
optical density determined at 540nm using SM22PC spectrophotometer (surgienfield 
Instruments, England). Haemolysis in each tube were expressed as a percentage, taking 
the tube with the highest heamolysis (i.e. Distilled water with 0.0%NaCl )as 100% 
 
Serum biochemistry  
 
 Whole blood were separated with high macro-centrifuge at 3,500 rpm for 10 
minutes and serum were separated by Pasteur pipette for analysis of the following 
biochemistry assays; Alkaline phosphate (ALP) as described by Tietz and Shuey (1986)19, 
aspartate aminotransferase(AST), (Bergmeyer et al., 1985)18, alanine aminotransferase 
(ALT)(Klauke et al., 1983)20 albumin (varely , 1994)21 and total protein (Keller, 1984)22. 
   All results were reported as mean + SEM. they were further analyzed using one way 
analysis of variants (ANOVA) followed by Tukey’s multiple comparison test. 
 
61 
 
6.2 DIURETIC ACTIVITY (LIPSCHITZ TEST) 
 
Aim 
  To study the Diuretic activity of Panchakkini Chenduram in Wistar albino rats by 
Lipschitz test induced method. 
 
Selection of animals: 
 
Healthy either sex of Wistar albino rats (150-200g) were used for this study with 
the approval of the institutional animal ethics committee and obtained from the animals 
laboratory.  
 
IAEC approved  Number: IAEC/XLIX/16/CLBMCP/2016 
 
       The animals kept in plastic cages and maintained at 22ºC +30ºC. All the rats were 
housed individually with free access to food, water and libitum. They were feed with 
standard diet and kept in well ventilated animals house they also maintained with 
alternative dark-light cycle of 12hours throughout the studies. Rats were allowed an 
acclimatization period of 7days before actual experiments. The rats were closely observed 
for any infection and if they show signs of infection they were excluded from the study. 
The animal experiment was performed with accordance legislation on welfare.   
 
Study design:23, 24 
 
Wistar rats were divided into five groups, consisting six rats for each group. 
Group (I) served as normal control (Vehicle) which received normal Saline water (10 
ml/kg orally) only. Group II received as furosemide orally dose of (10mg/kg, p.o), 
Groups (III) to (V) received Panchakkini Chenduram respectively at dose of 2.5mg/kg, 
5mg/kg and 10mg/kg respectively. Immediately after the extract treatment, all the rats are 
hydrated with saline (15 ml/kg) and placed in a metabolic cages. A total volume of urine 
collected for 6 hours was measured at the end. During this period no food and water were 
made available to animals. Various parameters like total urine volume and concentration 
of sodium, potassium and chloride in the urine were measured and estimated respectively. 
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Procedure 
 
The method of Lipschitz et al. was employed for the assessment of diuretic 
activity. All the animals were hydrated with double distilled water. Food and water were 
withdrawn 8hours  before the administration of drug. Immediately after dosing, all the 
animals were placed individually in metabolic cages and urine passed by the animals over 
a period of 24hours was collected in a conical flask. Total urine, output, electrolyte, pH 
was determined. 
 
Estimation of urine output 
 
Metabolic cage is designed with a stainless steel circular frame. The upper portion 
is covered with a lid, provided with a wire mesh bottom and a funnel for collecting the 
urine. Stainless steel sieves were placed in the funnel to retain the faeces, allowing only 
urine to flow down for collection and measurement. The whole structure is fixed to a 
metal frame, which keeps the frame in upright position. Conical flask is kept to collect the 
urine, at the bottom exit of the funnel for a period of 24h.Urine volume is expressed as 
ml/kg. The room temperature is maintained at 27-29°c. 
 
pH 
         A calibrated pH mater (model: WTW – series pH – 720) was used to estimate pH of 
the fresh urine samples.25 
 
Computation of diuretic index, Lipschitz value and Na+ /K+ ratio25 
 
The following equations were used to compute these parameters.  
Diuretic index  =   (UVt/UVc) ………………. (1) 
 Lipschitz value  =   (UVt/UVr) ...……………. (2)  
 Na+ /K+ ratio  =   (UNa+ /UK+ ) …....………..… (3) 
Where UVt = mean urine volume of test group, UVc = mean urine volume of control 
group, UVr = mean urine volume of reference group, UNa+ = concentration of Na+ in 
urine of a group, and UK+ = concentration of K+ in urine of a group. 
 
Statistical analysis25 
 
For determining the statistical significance, standard deviation, standard error 
mean and Dunnett’s test 1% level significance was employed. 
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6.3 HEMATINIC ACTIVITY OF PANCHAKKINI CHENDURAM 
 
Aim 
  To study the Hematinic activity of Panchakkini Chenduram in Wistar albino rats 
by Phenyl Hydrazine induced method. 
 
Selection of animals: 
 
Healthy either sex of Wistar albino rats (150-200g) were used for this study with 
the approval of the institutional animal ethics committee and obtained from the animals 
laboratory.  
 
IAEC approved  Number: IAEC/XLIX/16/CLBMCP/2016 
 
        The animals kept in plastic cages and maintained at22ºC + 30ºC. All the rats were 
housed individually with free access to food , water and libitum. They were feed with 
standard diet and kept in well ventilated animals house they also maintained with 
alternative dark-light cycle of 12hours throughout the studies. Rats were allowed an 
acclimatization period of 7days before actual experiments. The rats were closely observed 
for any infection and if they show signs of infection they were excluded from the study. 
The animals experiment were performed with accordance legislation on welfare.  
 
Experimental design:26 
 
 Anemia was induced by intraperioneal injection of phenylhydrazine at 40 mg/kg 
for 2days (d), as described by A   boudoulatif et al. (2008).  
   Following the injection, rats were divided in four groups of six rats each. 
Group I -  The control received distillated water 
Group II -  received phenylhydrazine only (anemic group) 
Group III -  received the Panchakkini Chenduram at dose of10mg  /kg /day  
Group IV - received standard as hematinic syrup (Dexorange, Franco –Indian  
  pharmaceuticals pvt. Limited, Mumbai) at 0.68ml/kg/day respectively.  
The vehicle, the trial medicine and standard were administered from day 2 to day 
15 after phenylhydrazine administration. 
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Collection of blood sample: 
 
      At the end of the experimental period, the animals were anaesthetized using 
chloroform vapour prior to dissection. Blood samples were collected from the caudal vein 
into a micro centrifuge tube containing 50nM ethylenediamine tetra acetic acid (EDTA) 
for the determinations of hematological profile. The blood was collected without EDTA 
to other test tubes. The blood was allowed to clot by standing at room temperature for 30 
minute and then refrigerated for another 30 minute. The resultant clear part was 
centrifuged at 3000rpm for 10minutes, and then the serum (supernatant) was isolated and 
store at refrigerated until required for analysis. 
 
Biochemical estimations  
 
 Malondialdehyde was estimated by the thiobarbituric acid assay method of Beuge 
and Aust (1978)27.  Reduced glutathione was estimated by method of Moron et al., 
(1979)28. Haemoglobin was estimated by Cyanmethaemoglobin method (Dacie and 
Lewis, 1968)29 (Beacon Diagnostic Kit). The serum GOT was estimated by the method of 
Reitman and Frankel (1957)30 RBC, Platelet  and WBC counted by the method of Ochei 
and  Kolhatkar, (2000)31. PCV counted by the method of Ochei and  Kolhatkar, (2000)31.      
 
Statistical Analysis: 
 
Values were expressed as mean ±SD for six rats in the each group and statistical 
significant differences between mean values were determined by one way analysis of 
variance (ANOVA) followed by the Tukey’s test for multiple comparisons.  The results 
were statistically analyzed by Graphpad Instat Software (Graphpad Software, San Diego, 
CA, USA) version 3 was used and p< 0.01 and p< 0.001 were considered to be 
significant.   
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
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7. RESULTS OF PANCHAKKINI CHENDURAM 
 
 
       Many studies have been carried out to bring the efficacy and potency of the drug 
Panchakkini Chenduram. The study includes literary collections, organoleptic character, 
physicochemical and phytochemical analysis, toxicological study and pharmacological 
study. The drug Panchakkini Chenduram has been selected from the text “Anuboga 
vaidya navaneetham, vol 1”. 
 
Ø Gunapadam review brings the effectiveness of the drug in the management of 
Liver Diseases, Oliguria, and Anaemia. 
Ø The pharmacological review explains about the Evaluation of  Hepatoprotective, 
Diuretic and Hematinic. 
 
STANDARDIZATION OF THE TEST DRUG 
 
Standardization of the drug is more essential to derive the efficacy, potency of the 
drug by analysing it by various studies. Following are the results of physicochemical and 
phytochemical analysis. Physical characterization and estimation of basic and acidic 
radicals have been done and tabulated. 
             
Toxicological results of the drug and pharmacological activity of the drug were 
derived. Its result has been tabulated and interpretation was made below. Thus it is to give 
a complete justification to bring the effectiveness of the trial drug Panchakkini 
Chenduram.   
 
ORGANOLEPTIC CHARACTER 
The following characters have been noted in Panchakkini Chenduram. 
 
Table: 1. ORGANOLEPTIC EVALUATION 
      Colour         Dark Brown 
      Odour        Unpleasant  
      Taste        Mild Astringent  
      Texture       Fine powder 
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PHYSICOCHEMICAL ANALYSIS  
 
Table: 2. Determination of Ash Values 
 
Percentage of Total Ash, Acid insoluble ash and Water Soluble ash values 
 
Parameter Percentage% 
Total Ash Value 70.56% 
Acid insoluble Ash 30.97% 
Water Soluble ash 26.76% 
 
Interpretation for ash values 
 
Ash: 
 
Ash constitutes the inorganic residues obtained after complete combustion of a 
drug. Thus Ash value is a validity parameter describe and to assess the degree of purity of 
a given drug. 
 
Total ash: 
 The Total ash value of the drug is 70.56% for Panchakkini Chenduram. 
 
Acid insoluble ash:  
The acid insoluble ash value of the drug is 30.97% for Panchakkini Chenduram.                  
 
Water Soluble ash: 
The Water Soluble ash value of the drug is 26.76% for Panchakkini Chenduram. 
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Table:3. Determination of Extractive Values 
Percentage of Alcohol Soluble and Alcohol Successive Soluble 
                        Parameter Percentage% 
             Alcohol Soluble              9.84% 
             Alcohol Successive Soluble            26.45% 
 
Interpretation for Extractive values 
Alcohol Soluble: 
The Alcohol Soluble value of the drug is 9.84% for Panchakkini Chenduram. 
 
Alcohol Successive Soluble: 
 
The Alcohol Successive Soluble value of the drug is 26.45% for Panchakkini 
Chenduram. 
 
Table:4. Determination of pH values 
pH values 
   Parameter  Values 
pH 8.2 
 
Interpretation for pH values: 
The pH value of the drug is 8.2 for Panchakkini Chenduram. 
 
Table:5. Loss on Drying 
Percentage Loss in weight on drying 
 
Parameter Percentage% 
Loss on drying 2.353% 
 
INTERPRETATION 
Ø The total of volatile content and moisture present in the drug was established in 
loss on drying.  
Ø Moisture content of the drug reveals the stability and its shelf-life.  
Ø High moisture content can adversely affect the active ingredient of the drug.  
Ø Thus low moisture content could get maximum stability and better shelf life. 
Ø The loss on drying value of the drug is 2.353% for Panchakkini Chenduram. 
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Chemical analysis 
 
The Chemical analysis shows the presence of Silicate, Phosphate, Iron and 
Magnesium in Panchakkini Chenduram. 
 
 
Table: 6. Chemical Analysis of Panchakkini Chenduram 
 
S.NO Parameters Results 
1. Silicate Present 
2. Sulphate Absent 
3. Chloride Absent 
4. Phosphate Present 
5. Carbonate Absent 
6. Nitrate Absent 
7. Sulphide Absent 
8. Oxalate Absent 
9. Nitrite Absent 
10. Borate Absent 
11. Lead Absent 
12. Copper Absent 
13. Aluminium Absent 
 
Interpretation 
 
 The acidic radicals test shows the presence of Silicate and Phosphate 
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Table: 7.Chemical Analysis of Panchakkini Chenduram 
 
 
 
Interpretation 
 
 The basic radical test shows the presence of Iron, Magnesium and absence of 
heavy metals such as lead, arsenic and mercury. 
 
 
S.NO             Parameters Results 
14. Iron Present 
15. Zinc Absent 
16. Calcium Absent 
17. Magnesium Present 
18. Ammonium Absent 
19. Potassium  Absent 
20. Sodium  Absent 
21. Mercury Absent 
22. Arsenic Absent 
23. Starch Absent 
24. Reducing sugar  Absent 
25. Alkaloids  Absent 
26. Tannic acid Absent 
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ANALYTICAL STUDY 
 
FT-IR SPECTRUM 
 
Result Analysis Interpretation  
Ø Strong intense peak at 466.11 cm-1 may be due to Fe- S stretching indicates the 
presence of Fe-S group 
Ø Wide intensity peal at 554.9 cm-1 may be due to the presence of S-S organic 
sulfide group 
Ø IR absorbance peal appears at 711.87  and 875.01 due to the –S stretching 
Ø Sharp intense peak at 1404.70cm-1 is due to presence of C-O stretching 
Ø Weak absorbance at 3410.53cm-1 may be due to NH primary amine stretching 
Ø IR absorption peak at 1625.59 cm-1 due to NH2 scissoring 
Ø IR absorption peak at 2513.68 and 3180.01cm-1 due to presence of O-H 
functional group stretching. 
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XRD ANALUSIS STUDY 
 
 Less intense peak appears at 1797.95 cm-1 due to presence of C=O stret 
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Result Analysis of XRD pattern of Panchakkini Chenduram 
 The X-ray diffraction pattern of the of the sample  Chenduram reveals the presence of  
major peak with 2- Theta value of 29.402  which exactly matches with the following 
ICDD‟s (International Centre for Diffraction Data) 65-2567, 07-0007,89-5892 and 
080247.  
 ICDD 65-2567 corresponds to the crystalline pattern of Iron Sulfide (FeS2)  
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Ø ICDD 07-0007 corresponds to the crystalline pattern of Ammonium Chloride 
(NH4Cl)  
Ø ICDD 89-5892 corresponds to the crystalline pattern of Iron Oxide (Fe2O3)  
Ø ICDD 08-0247 corresponds to the crystalline pattern of Sulfur (Fe2O3) 
Ø Major peaks observed in test sample Chenduram with 2-theta values of 29.402 
and their corresponding intensities were 933.  
Ø The major peak observed in the reference matching material Fes2 was 33.22 with 
the intensity value of 999 and in NH4Cl it was 32.65 with intensity value of 100.  
Ø Similarly the major peak observed in the reference matching material Fe2O3 was 
35.65 with the intensity value of 999 and in sulfur it was 23.08 with intensity 
value of 100.  
Ø The XRD pattern of the test sample (Chenduram) matches with the following 
reference materials such as Iron Sulfide, Ammonium Chloride, Iron Oxide and 
sulfur which justifies the presence of stable and purified nature of above 
mentioned compounds in the form ingredients in the test sample.  
Ø From the result of the present XRD analysis it was concluded that the elemental 
composition of Chenduram comprises of the mixture of Iron Sulfide, Ammonium 
Chloride, Iron Oxide and sulfur. 
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SEM ANALYSIS 
 
Figure 1 :  SEM image of Panchakki Chenduram – Cluster View 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
74 
 
 
SEM image of Panchakki Chenduram – Categorised View 
 
 
 
 
Figure 1A :  Particle Size ranges from 21.5 to 46.23 μm  Average particle size 
  
Mean                : 34.83 
Std Deviation     : 9.931 
Std Error             : 3.511 
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SEM image of Panchakkini Chenduram-Categorised View 
 
Figure 1B: Particle Size ranges from 15.08 to 30.7 μm   Average Particle size  
Mean   :  21. 39  
Std. Deviation  : 4.745 
Std. Error   : 1.678 
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UV INTERPRETATION REPORT OF PANCHAKKINI CHENDURAM 
 
 
 
 
 
 
 
 
 
 
 
Report 
 
Ø The λ max value of the sample Panchakkini Chenduram projects intense 
absorbance at 302.72 nm and 384.33 nm 
Ø Excitation maximum of  sample at 302.72nm is a characteristic feature of 
presence of sulfide group 
Ø Absorbance at 384.33 may be due to the presence of Iron oxide 
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ACUTE TOXICITY STUDY 
 
Results: 
 All data were summarized in tabular form,(Table-9-12) showing for each test 
group the number of animals used, the number of animals displaying signs of toxicity, the 
number of animals found dead during the test, description of toxic symptoms, weight 
changes, food and water in take No of animals in each group:3  
 
Table: 9 
(Observational study Results) 
 
No 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. Control + - - + - + - - - - - - - - - - - - - - 
2. 
2000mg 
 
+ - - + - + - - - - - - - - - - - - - - 
 
1.Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 11. 
Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 15.Lacrimation 16. 
Exophthalmos 17. Diarrhea 18. Writhing  19. Respiration 20. Mortality. 
 
(+) indicates the presence 
(-)   indicates the absence 
 
Interpretation  
 
The acute toxicity result shows no mortality rate up to dose level of 2000mg/kg. It 
showed changes in alertness, grooming, touch response and grip strength. The normal 
behavioural changes were observed in first hours and no mortality were reported after 14 
days observation. Hence the test drug Panchakkini Chenduram is a safe up to the dose of 
level of 2000mg/kg in oral administration. 
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Table: 10  ( Body weight Observation) Body weight (kg/day) of Wistar albino rats 
group exposed to Panchakkini Chenduram. 
 
 
 
 
 
 
 
 
Table: 11 Water intake (ml/day) of Wistar albino rats group exposed to Panchakkini  
Chenduram. 
DOSE 
 
DAYS 
1 7 14 
CONTROL 58 ± 1.02 58±9.20 59.4±1.04 
HIGH DOSE 59.4±2.20 59.8±3.40       
59.9±6.24 
P value (p)* NS NS NS 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One-way ANOVA followed by Dunnett’s test) 
 
Table 12: Food intake (gm/day) of Wistar albino rats group exposed to Panchakkini                    
Chenduram 
 
DOSE 
 
DAYS 
1 7 14 
CONTROL 61.04±2.62 62.2±4.76 64.3±6.26 
High DOSE 69.4±4.23 70.4±6.22 71.6±4.18 
 
 
DOSE 
 
DAYS 
1 7 14 
CONTROL 320.2±42.30  322.4 ± 60.10 323.6 ±52.10 
HIGH DOSE 302.4± 1.21 302 ± 2.04 304.2 ± 2.10 
P value (p)* NS NS NS 
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RESULTS  
 
Repeated Dose 28- day oral toxic study of Panchakkini Chenduram Body 
weight of  Wistar albino rats group exposed to Panchakkini Chenduram 
 
Table 13 
 
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
 
Table 14: Water intake (ml/day) of Wistar albino rats group exposed to Panchakkini  
                 Chenduram 
 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 60.1 ± 8.72      60±1.52 60.2±1.40 61±1.32 61.4±1.62 
LOW DOSE 65.1±1.21 65.6±4.22 66.6±1.02 65.2±2.06 66.4±1.20 
MID DOSE 62.1±1.02 62.3±1.21 62.1±2.62 63.4±4.32 63.4±1.64 
HIGH DOSE 64.1±1.81 64.2±1.32 64.4±1.14 64.6±1.62 65.8±2.02 
P value (p)* NS NS NS NS NS 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 235.2±18.46 
236.5 ± 
35.10 
236.6 ± 45.60 
238.7± 
56.16 
238.4 ± 
66.15 
LOW DOSE 
248.2 ± 
65.24 
250.7 ± 
66.28 
254.6± 55.34 
256 
±56.34 
256.8± 
35.36 
MID DOSE 252.4± 18.34 
253.3 ± 
16.24 
253.4 ± 14.12 
255.2 ± 
15.20 
256.4 ± 
54.10 
HIGH DOSE 261.6± 62.24 261.4±42.22 262.4 ± 52.24 
263 ± 
54.28 
264 ± 74.60 
P value (p)* NS NS NS NS NS 
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Table 15: Food intake (gm/day) of Wistar albino rats group exposed to Panchakkini  
 Chenduram 
 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 34±4.14 34.2±6.12 34.3±2.18 34.2±1.14 34±5.62 
LOW DOSE 36.3±1.64 36.3±1.51 36.2±1.51 36.5±1.62 36.5±1.22 
MID DOSE 34.1±2.12 34.2±3.50 34.2±2.14 34.2±2.16 35.2±1.64 
HIGH 
DOSE 
32.4±1.62 32.1±1.64 32.6±2.36 32.6±1.20 36.4±2.32 
P value (p)* NS NS NS NS NS 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test 
 
Table 16: Haematological parameters of Wistar albino rats group exposed to  
Panchakkini Chenduram 
 
 
Category Control Low dose Mid dose High dose P value (p)* 
Haemoglobin(g/dl) 13.4±0.71 13.30±0.14 13.4±0.13 13.72±0.13 N.S 
Total WBC (×103 l) 9.41±0.22 9.32±0.22 9.34±0.22 9.30±1.10 N.S 
Platelets cells103/µl 900.17±3.18 902.11±4.62 902.11±2.20 902.22±2.64 N.S 
Total RBC 106/µl 9.32±0.11 9.47±0.33 9.50±0.64 9.60±0.46 N.S 
Neutrophils (%) 12.13±0.60 12.02±0.52 12.11±1.42 12.02±2.71 N.S 
lymphocyte (%) 82.10±1.26 82.12±1.42 83.10±2.44 83.20±2.54 N.S 
Monocyte (%) 1.1±0.03 1.1±0.01 1.2±0.04 1.1±0.03 N.S 
Eosinophil (%) 0.8±0.03 0.8±0.04 0.9±0.05 0.9±0.08 N.S 
PCV% 48.10±0.2 48.62±5.30 48.8±4.70 48.4±.71 N.S 
MCHC g/Dl 36.5±1.61 36.2±1.51 36.8±1.30 36.13±1.60 N.S 
MCV fL(µm3) 58.2±2.02 58.2±1.80 58.7±1.10 59.7±1.30 N.S 
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N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test) 
 
The mean value of Hb%  and T.RBC of control and treated groups of Wistar 
albino rats exposed to Panchakkini Chenduram in repeated oral 28 Days toxic study. 
 
Chart- 1 
 
 
The mean value of T.WBC and  Platelets of control and treated groups of Wistar 
albino rats exposed to Panchakkini Chenduram in repeated oral 28 Days toxic study. 
 
Chart- 2 
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The mean value of Neutrophils and Lymphocytes of control and treated groups of 
Wistar albino rats exposed to Panchakkini Chenduram in repeated oral 28 Days toxic 
study. 
 
Chart- 3 
 
 
 
The mean value of Monocytes and Eosinophils  of control and treated groups of 
Wistar albino rats exposed to Panchakkini Chenduram in repeated oral 28 Days toxic 
study. 
Chart - 4 
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The mean value of PCV,MCV and MCHC of control and treated groups of Wistar 
albino rats exposed to Panchakkini Chenduram in repeated oral 28 Days toxic study. 
 
Chart – 5 
 
 
 
Table17: Biochemical Parameters of of Wistar albino rats group exposed to  
Panchakkini Chenduram 
 
BIOCHEMICAL 
PARAMETERS 
CONTROL 
LOW 
DOSE 
MID 
DOSE 
HIGH 
DOSE 
P 
Value 
(p)* 
GLUCOSE (R) (mg/dl) 138.10±2.02 
138.12±2.1
0 
138.9±12.6 
138.12±5.2
5 
N.S 
T.CHOLESTEROL(mg
/dl) 
52.14±5.10 53.15±5.20 53.40±1.68 53.21±1.10 N.S 
TRIGLY(mg/dl) 54.15±1.82 54.11±1.32 54.15±1.22 56.16±1.21 N.S 
LDL 39.6±2.13 39.7±2.05 39.10±1.03 
39.40±01.3
2 
NS 
VLDL 14.2±1.52 14.20±2.41 14.02±1.32 14.04±12.1 NS 
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5 
HDL 12.12±4.32 12.32±2.50 12.46±1.20 12.51±1.23 NS 
Ratio 1(T.CHO/HDL) 3.73±1.16 3.72±1.80 3.73±1.32 3.74±2.33 NS 
Ratio 2(LDL/HDL) 1.92±1.22 1.92±1.20 1.93±2.20 
1.94±006.0
2 
   NS 
Albumin (g/dL) 4.21±0.22 4.22±0.52 4.4±7.20 4.55±6.48 NS 
 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
 
       The mean value of T.Cholesterol, Triglyceride and  Glucose of control and treated 
groups of Wistar albino rats exposed to Panchakkini Chenduram in repeated oral 28 
Days toxic study. 
 
Chart– 6 
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The mean value of LDL VLDL and HDL of control and treated groups of Wistar 
albino rats exposed to Panchakkini Chenduram in repeated oral 28 Days toxic study. 
Chart – 7 
 
 
 
The mean value of Ratio 1 (T.Cho/HDL) and radio to LDL / HDL of control and 
treated groups of Wistar albino rats exposed to Panchakkini Chenduram in repeated oral 
28 Days toxic study. 
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The mean value of Albumin of control and treated groups of  Wistar albino 
rats exposed to Panchakkini Chenduram in repeated oral 28 Days toxic study. 
Chart - 9 
 
 
Table 18: Renal function test of of Wistar albino rats group exposed toPanchakkini  
                  Chenduram 
PARAMETERS 
 
CONTR
OL 
LOW 
DOSE 
MID 
DOSE 
HIGH 
DOSE 
P Value 
(p)* 
UREA (mg/dl) 
15.50±0.2
9 
15.50±0.29 15.46±1.18 15.42±1.22 N.S 
CREATININE(mg/dl) 0.58±0.02 0.60±0.04 0.58±0.03 0.58±0.09 N.S 
BUN(mg/dL) 19.1±0.02 19.10±0.34 19.6±0.42 19.26±1.02 NS 
URIC ACID(mg/dl) 1.02±0.04 1.06±0.21 1.4±0.12 1.20±0.10 N.S 
 
NS- Not Significant, **(p > 0.01), * (p >0.05) , n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test) 
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The mean value of Urea, Creatinine, BUN and Uric acid of control and treated 
groups of Wistar albino rats exposed to Panchakkini Chenduram in repeated oral 28 Days 
toxic study. 
Chart - 10 
 
 
 
Table 19: Liver Function Test of  Wistar albino rats group exposed to Panchakkini  
                 Chenduram 
PARAMETERS CONTROL 
LOW 
DOSE 
MID DOSE 
HIGH 
DOSE 
P 
Value 
(p)* 
T. BILIRUBIN 
(mg/dl). 
0.25±0.01 0.26±0.03 0.25±0.03 0.26±0.01 N.S 
SGOT/AST(U/L) 114.11±1.53 114.12±0.22 114.24±1.54 114.74±1.53 N.S 
SGPT/ALT(U/L) 34.21±1.02 33.34±1.04 34.44±1.16 33.38±0.21 N.S 
ALP(U/L) 112.11±2.21 112.22±2.20 112.23±1.24 112.03±6.02 N.S 
T.PROTEIN(g/dL) 7.2.40±0.14 7.2±0.41 7.2±0.60 7.3±0.61 N.S 
 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test 
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The mean value of T.Bilirubin and T.Protein of control and treated groups of 
Wistar albino rats exposed to Panchakkini Chenduram in repeated oral 28 Days toxic 
study. 
Chart - 11 
 
 
The mean value of SGOT/AST, SGPT/ALT and ALP of control and treated groups of 
Wistar albino rats exposed to Panchakkini Chenduram in repeated oral 28 Days toxic 
study. 
Chart - 12 
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HISTOPATHOLOGY OF VITAL ORGANS 
         Control                     High power Magnification 40x  High Dose  
 
 
 
 
 
 
 
Brain          Brain  
 
    Heart       Heart  
        
 
 
 
 
 
   Kidney       Kidney  
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Liver        Liver  
 
 
 
 
 
 
 
Lungs            Lungs   
Interpretation: 
Liver: 
      Section of liver from control animals showed No degeneration of hepatocytes, focal 
steatosis, and congestion of central vein and inflammation of portal tract.  Liver of treated 
groups showed No degeneration of hepatocytes, focal steatosis, and congestion of central 
vein and inflammation of portal tract  
 
Kidney: 
Section of kidney from control animals showed normal size of glomeruli with 
normal tubules. Kidney of treated animals showed normal glomeruli and there is no 
necrosis of tubular epithelium in the kidney. 
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Lungs: 
    Section of lungs from control animal showed normal architecture of a section and the 
drug treated group shows mild paraseptal thickening with inflammation 
 
Brain: 
      Section of brain from control animals showed brain cortex with normal architect. 
Treated animals showed brain cortex with normal architecture. 
 
Heart: 
         Section of heart from control animal showed normal muscle fibers with acidophilic 
cytoplasm and centrally located nuclei  
 
         In treated group showed normal muscle fibers with acidophilic cytoplasm and 
centrally located nucleiwith normal structure. 
 
Heart, Lungs, brain, liver and kidney showed no cellular architecture in treated 
groups. From the histopathological study no related changes in vital organs are observed 
in treated groups. 
 
Results: 
All animals from control and all the treated dose groups survived throughout the 
dosing period of 28 days for subacute toxicity study. The results for body weight 
determination of animals from control and different dose groups show comparable body 
weight gain throughout the dosing period of 28 days. During dosing period, the quantity 
of food and water consumed by animals from different dose groups was found to be 
comparable and normal with that by control animals. 
 
The results of haematological investigations conducted on day 29th day revealed 
no significant changes in the haematological values when compared with those of 
respective controls. This gave clear justification that bone marrow and spleen were not 
influenced by Panchakkini Chenduram. 
 
Results of Biochemical investigations conducted on days 29 and recorded in 
revealed the no significant changes in the values of different parameters studied when 
compared with those of respective controls; Urea, SGOT,SGPT, Bilirubin were within the 
limits, blood glucose significant compared to control group.   
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The other cardio vascular risk markers were also within normal ensured that 
Panchakkini Chenduram did not influence the Cardio vascular system.  
 
Group Mean Relative Organ Weights are recorded Comparison of organ weights 
of treated animals with respective control animals on day 29 was found to be comparable 
with respective control group. Gross pathological examination of animals in control as 
well as the treated groups did not reveal any abnormalities.  
 
         The vital organs such as liver, heart, kidneys, lungs and brain were removed from 
the test groups at the end of the study and carefully observed macroscopically to find any 
observable gross lesions compared with the control group and did not reveal any 
abnormal macroscopic changes. Gross pathological investigation was carried out and 
histopathology of vital organ reveled normal histological appearance when compared 
with the control. According to these results, Panchakkini Chenduram could be concluded 
as no-observed-adverse-effect level (NOAEL). It showed the safety of the drug which 
proved its utility in long time administration without any harm to the human being. 
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RESUIT OF REPEATED DOSE 90 DAYS ORAL TOXITY STUDY IN WISTAR 
RATS 
Table 20: Body weight of Wistar albino rats group exposed to Panchakkini                 
Chenduram 
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test 
 
Table 21: Water intake (ml/day) of Wistar albino rats group exposed to Panchakkini  
                 Chenduram 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test 
 
 
DOSE 
 
DAYS 
1 15 30 45 60 75 90 
CONTROL 300.2±12.03  
301.2 ± 
14.14 
301.6 ± 
20.42 
302.4 ± 
13.50 
302.5 ± 
12.20 
304±16.20 304±15.02 
LOW DOSE 310.2 ± 20.20 
310.5 ± 
2.24 
312.4± 
12.21 
322 ± 
04.12 
323.02± 
20.50 
324±03.20 326±12.32 
MID DOSE 308.4± 32.50 
308.3 ± 
20.05 
308.4 ± 
20.20 
309.4 ± 
10.20 
310.6 ± 
20.02 
310±22.14 310±16.26 
HIGH 
DOSE 
280± 12.10 
280 ± 
12.30 
280±04.22 
281 ± 
30.16 
281.32 ± 
04.10 
281±11.10 282±16.34 
P value (p)* NS NS NS NS NS NS NS 
DOSE 
 
DAYS 
1 15 30 45 60 75 90 
CONTROL 98.4 ± 
1.25 
98±1.02 98.8±2.30 98±5.12 98.5±1.06 99.25±7.16 99±77.50 
LOW DOSE 97.2±6.40 97.4±8.50 97.6±1.14 98.2±1.40 98.4±1.50 98.4±1.56    98±2.84 
MID  
DOSE 
95.4±2.10 95.3±2.24 95.12±2.02 96.4±2.17 96.5±1.32 96.4±1.50 96.2±1.42 
HIGH 
DOSE 
87.1±1.30 87.2±2.20 87.7±4.52 87.2±1.82 87.4±6.78 88±4.51 89±2.20 
P value (p)* NS NS NS NS NS NS NS 
94 
 
Table 22: Food intake (gm/day) of Wistar albino rats group exposed to Panchakkini  
                 Chenduram 
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test 
 
Table 23: Haematological parameters of Wistar albino rats group exposed to 
Panchakkini  Chenduram 
Category Control Low dose Mid dose High dose 
P 
value 
(p)* 
Haemoglobin(g/dl) 13.2±0.20 13.10±0.33 13.15±0.76 13.38±0.46 N.S 
Total WBC (×103   
l) 
13.92±0.05 13.62±0.33 13.94±0.20 13.40±9.06 N.S 
Platelets cells103/µl 724.15±2.26 724.17±4.76 725.19±3.62 725.05±2.14 N.S 
Neutrophils(%) 11.12±0.04 11.15±0.60 11.25±1.54 11.10±2.40 N.S 
Lymphocyte (%) 85.12±1.21 85.20±1.14 85.21±1.06 85.15±1.26 N.S 
Monocyte (%) 2.45±0.02 2.87±0.04 2.56±0.06 2.87±0.07 N.S 
Eosinophil(%) 0.80±0.04 0.81±0.07 0.83±0.02 0.80±0.03 N.S 
Total RBC 106/µl 7.42±0.03 7.64±0.70 7.24±0.27 7.82±0.32 N.S 
DOSE 
 
DAYS 
1 15 30 45 60 75 90 
CONTROL 224.6±1.22 225±5.04 225.6±6.20 226±4.96 228.2±2.12 229.32±1.26 229±24.32 
LOWDOSE 221.2±1.22 221.2±1.42 221.4±3.13 221.2±2.14 221.8±1.22 222.8±2.23 223.6±2.54 
MID DOSE 242.7±4.33 243.3±2.21 244.14±2.02 244.4±1.42 245.2±2.20 246.1±2.20 247±2.12 
HIGHDOSE 246.1±1.43 246.2±2.61 246.6±2.40 247.2±1.20 247.4±2.40 248±2.24 248±2.80 
P value (p)* NS NS NS NS NS NS NS 
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PCV% 48.50±0.6 48.10±1.20 48.70±1.52 49.16±2.14 N.S 
MCHC g/Dl 36.4±1.42 36.6±0.72 36.7±2.80 36.30±1.74 N.S 
MCV fL(µm3) 53.04±4.60 53.06±3.30 53.20±2.32 54.24±2.24 N.S 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
 
The mean value of Hb and PCVof control and treated groups of Wistar albino rats 
exposed to Panchakkini Chenduram in repeated oral 90 Days toxic study. 
 
Chart- 13 
 
   
0
10
20
30
40
50
60
Control Low dose Mid dose High dose
Hb and PCV
Hb
PCV
96 
 
The mean value of T.WBC and Platelets of control and treated groups of Wistar albino 
rats exposed to Panchakkini Chenduram in repeated oral 90 Days toxic study. 
Chart- 14 
 
 
The mean value of Neutrophils and Lymphocytes of control and treated groups of 
Wistar albino rats exposed to Panchakkini Chenduram in repeated oral 90 Days toxic 
study. 
Chart- 15 
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The mean value of Monocyte and Eosinophil of control and treated groups of 
Wistar albino rats exposed to Panchakkini Chenduram in repeated oral 90 Days toxic 
study. 
Chart- 16 
 
 
The mean value of T.RBC of control and treated groups of Wistar albino rats 
exposed to Panchakkini Chenduram in repeated oral 90 days toxic study. 
Chart- 17 
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The mean value of MCV and MCHC of control and treated groups of Wistar 
albino rats exposed to Panchakkini Chenduram in repeated oral 90 Days toxic study. 
Chart- 18 
 
 
Tab24: Liver Function Test of Wistar albino rats group exposed to Panchakkini  
              Chenduram 
 
Group Treatment 
Glucose 
(mg/dL) 
Triglycerides 
(mg/dL) 
Cholesterol 
(mg/dL) 
SGPT (U/L) 
ALP 
(U/L) 
I Control 82.64±2.11 46.24±09.32 46.81±4.45 52.22±3.39 215.08±12.48 
II Low dose 96.84±10.24 56.34±6.22 47.04±2.43 70.87±6.57 280.60±17.68 
III High dose 98.63±09.24 58.44±7.74 52.20±6.46 82.11±1.24 312.44±12.94 
 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test) 
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The mean value of Glucose, Triglycerides and Cholesterol of control and treated 
groups of  Wistar albino rats exposed to Panchakkini Chenduram in repeated oral 90 
Days toxic study. 
Chart- 19 
 
 
The mean value of SGPT and ALP of control and treated groups of  Wistar albino 
rats exposed to Panchakkini Chenduram in repeated oral 90 Days toxic study. 
Chart- 20 
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Table 25: Biochemical Parameters of of Wistar albino rats group exposed to 
Panchakkini  Chenduram 
Group Treatment 
BUN 
 (mg/dL) 
LDL 
 (U/L) 
T. Protein 
(g/dL) 
Albumin 
(g/dL) 
Creatinine 
(mg/dL) 
I Control 12.40±0.20 318.18±44.15 2.36±0.42 0.70±0.04 0.14±0.04 
II Low dose 13.46±0.90 348.40±18.19 3.84±0.24 1.33±0.19 0.31±0.04 
III High dose 14.24±1.22 390.10±42.03 4.14±0.12 1.85±0.11 0.32±0.02 
 
The mean value of BUN and Creatinine of control and treated groups of Wistar 
albino rats exposed to Panchakkini Chenduram in repeated oral 90 Days toxic study. 
 
Chart- 21 
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The mean value of T.Protein and Albumin of control and treated groups of  Wistar 
albino rats exposed to Panchakkini Chenduram in repeated oral 90 Days toxic study. 
Chart- 22 
 
The mean value of LDL of control and treated groups of Wistar albino rats 
exposed to Panchakkini Chenduram in repeated oral 90 Days toxic study. 
 
Chart- 23 
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Histopathology of Control group animals 
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Brain 
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  Histopathology of High dosed group animals 
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Interpretation 
Kidney 
v Appearance of glomeruli, tubules, interstitium and lumen was normal in both the 
samples with no signs of degeneration  
v Interstitial connective tissue of both the sample appear normal 
 
Heart 
v Perfectly -arranged myocardial fibers, clear transverse striation and normal 
structure were observed. 
v Appearance of cardiomyocyte was normal with dark nuclear region. The nuclei of 
muscle fibers appear oval arrangement. 
 
Liver 
v Hepatocyte appears with dark pigment chromatin in centri lobular and periportal 
region 
v Hepatic sinusoid and hepatic cord was normal 
 
Lung 
v Lung parenchyma appears normal with regular arrangement of alveoli and 
alveolar sac with no signs of lymphocyte infiltration and pulmonary fibrosis 
v Perivascular region appears normal, Alveolar septa and wall appeared widen and 
normal 
v No signs of lymphocyte cuffing 
v No signs of airway secretion and bronchial secretion 
v Bronchial blood vessels and connective tissue appears normalwith no signs of 
pulmonary edema 
 
Brain 
v Arrangement of the neurons appears intact with no signs of degeneration or 
apoptotic changes in both the samples 
v Cortex region showed normal neurons with polygonal to round cell bodies 
containing dense cytoplasm. 
v No signs of ischemia or lesion were observed  
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Interpretation of sub-chronic toxicity study: 
 
Sub-chronic oral toxicity repeated dose of Panchakkini Chenduram on rats were 
conducted. All animals from the treated dose survived throughout the dosing period of 90 
days. Various parameters were studied and the interpretation of the study result is 
discussed below. 
 
Body weight 
 
The result of the body weight of rats exposed to control and the Panchakkini 
Chenduram  of different dose groups exhibited overall weight gain throughout the dosing 
period of 90 days. The quantity of food taken by the animals from different dose groups 
and the control is comparably normal. 
 
 
Haematological investigation interpretation: 
               
The haematological investigation results of the rats conducted on 91st   day after 
the repeated dose of the drug revealed the values of different parameters.. The increase 
and decrease in the values obtained were all within the normal biological and laboratory 
limits. 
 
Biochemical investigation interpretation: 
 
      The biochemical investigations were conducted on 90th day and the result is 
produced. The results revealed there are no significant changes in the values of different 
parameters with that of the control. But sugar levels were reduced significantly. other 
values were within the normal biological and laboratory limits. 
 
Histopathology 
 
Gross pathological examination of animals in control as well as the treated groups 
did not reveal any abnormalities.  
 
The vital organs such as liver, heart, kidneys, lungs and brain were removed from 
the test groups at the end of the study and carefully observed macroscopically to find any 
observable gross lesions compared with the control group and did not reveal any 
abnormal macroscopic changes. Gross pathological investigation was carried out and 
histopathology of vital organ reveled normal histological appearance when compared 
with the control. 
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PHARMACOLOGICAL RESULTS OF HEPATO PROTECTIVE   ACTIVITY 
Table26: Effect of Panchakkini chenduram and Silymarin on haematological 
parameters of Paracetamol induced liver damage in rats 
Parameters Control 
Control+ 
PCM  1g/kg 
Silymarin 
100 mg/kg+ 
PCM 1g/kg 
PC 5mg/kg+ 
PCM 1g/kg 
PC10mg/kg+
PCM 1g/kg 
PCV (%) 44.31±1.76 21.37±1.26 ### 28.47±1.20 31.53±2.02 * 33.67±1.26 ** 
Hb (g/dl) 15.00±0.57 11.60±0.70### 12.67±0.33 13.53±0.17 ** 13.43±0.23 
*** 
RBC (x 106/µ 
L) 
6.33±0.17  5.30±0.11 ### 5.76±0.12* 6.333±0.18 * 6.033±0.26 ** 
Platelets (x 
103/µ L 
160.0±2.30  95.67±3.18 ### 114.17±2.40 
** 
124.3±1.76 ** 125.7±2.90 
*** 
MCV 60.77±0.88 43.45±3.52 ### 45.70±2.08 52.33±1.20 *  54.30±2.00 * 
MCH 23.13±1.85 13.63±1.20 # 12.87±0.88 14.33±1.76 15.27±2.40 
MCHC 45.42±1.73 42.30±1.73 # 47.67±0.81 41.67±2.18 34.67±2.40 
WBC X 10 3 6.73±0.59 8.87±0.17*** 7.10±0.17 8.46±0.14 # 7.63±0.20 ### 
 
PC – PANCHAKKINI CHENDURAM            PCM- PARACETAMOL 
Values are Mean ± SEM; n = 6 animals in each group: # P<0.05, ## P< 0.01, ###P<0.001 
is considered significant when compared with group I; *P<0.05, **P< 0.01, ***P<0.001 
is considered significant when compared with group II by Tukey multiple comparison 
test.  
 
110 
 
Chart- 24 
 
 
Chart- 25 
 
 
 
 
 
 
0
10
20
30
40
50
PCV and Hb
PCV
Hb
0
2
4
6
8
RBC and WBC
RBC
WBC
111 
 
 
 
Chart-26 
 
 
Chart- 27 
 
 
 
0
20
40
60
80
100
120
140
160
180
Pl
at
el
et
s 
(x
 1
0³
/µ
 L
Platelets
0
10
20
30
40
50
60
70
MCH, MCHC and MCV
MCH
MCHC
MCV
112 
 
Table 27: Effect of Panchakkini Chenduram and Silymarin on serum enzymes 
(SGPT, SGOT and ALP, Total bilirubin and Total protein on Paracetamol (PCM) 
induced liver damage in rats 
 
 
PC- PANCHAKKINI CHENDURAM             PCM-PARACETAMOL 
 
Values are Mean ± SEM; n = 6 animals in each group: #P<0.05, ##P< 0.01, 
###P<0.001 is considered significant when compared with group I; *P<0.05,  **P< 0.01, 
***P<0.001 is considered significant when compared with group II by Tukey multiple 
comparison test. 
 
 
Paramet
ers 
Control Control+ 
PCM  1g/kg 
 Silymarin 
100 mg/kg+ 
PCM 1g/kg 
PC 
5mg/kg+ 
PCM 1g/kg  
PC10mg/kg
+PCM 
1g/kg 
SGOT 
(IU/L) 
157.3±24.65 300.35±10.73 213.87±6.26* 250.77±4.45 
** 
160.±4.45 
** 
SGPT 
(IU/L) 
72.3±14.79  278.05±8.71### 57.67±3.66 ** 60.27±4.26*
* 
30.27±4.26 
ALP 
(IU/L) 
42.35±1.76  77.67±1.76 ### 41.67±2.70 
*** 
53.63±1.36 
*** 
51.63±1.36 
*** 
Total  
Bilirubin 
(mg/dl) 
11.03±1.20  15.73±0.45### 6.66±0.85* 3.26±0.40 
*** 
3.06±0.40 
*** 
Total 
Protein 
(mg/dl) 
3.506±0.78 7.76±1.28### 9.83±0.38* 12.67±2.58 * 12.67±2.58 
* 
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Table 28 : Effect of Panchakkini Chenduram  and Silymarin on serum Creatinine 
and Urea, on Paracetamol (PCM) induced liver damage in rats 
 
Parameters Control Control+ 
PCM  
1g/kg 
Silymarin 
100 
mg/kg+ 
PCM 
1g/kg 
PC 
5mg/kg+ 
PCM 
1g/kg 
PC10mg/kg+PCM 
1g/kg 
Creatinine 
(mg/dl) 
0.74±0.05 1.40±0.12 1.33±0.21 1.26±0.25 1.15±0.15 
Urea (mg/dl) 17.57±2.18 84.77± 
4.80 *** 
55.23±4.91 
## 
42.04±4.36 
### 
36.13±4.45 ### 
 
 
Values are mean ± SEM. ***P<0.001, **P<0.01, *P<0.05 compared to control rats.### 
P<0.001, ##P<0.01, #P<0.05 compared with group II by Tukey multiple comparison test. 
 
Chart- 30 
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Cr
ea
ti
ni
ne
 (m
g/
dl
)
Creatinine
115 
 
Chart- 31 
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Histopathological Report: 
Group 1: Control    Group2: Control+PCM  1g/kg 
    
Group 3: Silymarin 100mg/kg + PCM 1g/kg  Group 4 : PC 5mg/kg+PCM 1g/kg  
 
   
Group 5: PC 10mg/kg + PCM 1g/kg 
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Interpretation: 
Hepatoprotective activity was carried out in Paracetamol induced Wistar albino 
rats. Paracetamol induced hepatotoxicity. The effects observed were compared with a 
known hepatoprotective agent, silymarin. In the acute liver damage induced by different 
hepatotoxins, Panchakkini Chenduram (5mg/kg and 10mg/kg, po) significantly reduced 
the elevated serum levels of aspartate aminotransferase, alanine aminotransferase, 
alkaline phosphatase and bilirubin. The higher dose of the PCM (1 mg/kg, po) prevented 
the increase in liver weight when compared to hepatoxin treated control, while the lower 
dose was ineffective except in the paracetamol induced liver damage. Histological 
examination of the liver tissues supported the hepatoprotection. It is concluded that the 
the Panchakkini Chenduram possesses good hepatoprotective activity. From the blood 
samples collected PCV, Hb concentration, MCV, MCH, MCHC, RBC and WBC count 
were determined. 
 
 
Conclusion: 
In the present study the above parameters analyzed, it may concluded that 
Panchakkini chenduram has significant produced hepatoprotective activity against 
Paracetamol induced rat. 
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PHARMACOLOGICAL   RESULT OF DIURETIC ACTIVITY 
Table 29: 
Groups 
Total Urine Vol 
(ml/kg/6hrs) 
Na+ mmol/L K+ mmol/L Cl- mmol/L 
Control 
(10ml/kg ) 
14.34±0.37 104.0±2.30 48.67±2.02 76.23±2.80 
Furosemide  
(10mg/kg) 
28.56±0.83 *** 190.0 ±2.30 *** 72.67±1.45*** 102.97±5.51 *** 
Panchakkini 
Chenduram 
(2.5mg/kg) 
15.45 ±0.29 ### 126.3 ±4.05 ### 52.00±2.30### 74.37±2.49 ### 
Panchakkini 
chenduram 
(5 mg/kg) 
16.57 ±0.03 ### 148.0 ±2.30 ### 63.00±1.15 
### 
88.77±2.20 ## 
Panchakkini 
Chenduram 
(10mg/kg) 
17.57 ±0.03 ### 140.0 ±2.30 ### 60.00±1.15 
### 
90.77±2.20 ## 
 
Values given are as means ± S.E.M, n=6. All the value are compared with the control 
group(normal saline treated); p<0.001 
 
119 
 
Chart- 32 
 
 
 
Interpretation: 
 
Results of study were represented in Table- 29 .They shows the values of urinary 
volume, Sodium, Potassium and chloride levels. 
The control group showed increased urinary sodium potassium and chloride levels 
compared to standard and drug administrated groups. Significant differences were 
observed between standard and Panchakkini Chenduram treated groups (Group III, IV 
and V). When compared to lipscitz value of Panchakkini Chenduram treated groups, so it 
is considered as moderate Diuretic. 
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PHARMACOLOGICAL   RESULT OF HEMATINIC ACTIVITY 
Table 30 : Effect of Panchakkini chenduram on Hb, PCV and RBC content in 
experimental rats   
 
Parameters Control 
Phenylhydrazine 
(40mg/kg) 
   
PC(10mg/
kg) 
Hematinic 
syrup(0.68ml
/kg/day) 
Hb (gm/dl)   
13.84 ± 
3.63 
5.46 ± 2.04# 
8.76 ± 
2.56* 
12.73 ± 1.12*  
PCV (%) 46± 3.36 38 ± 2.17# 45 ± 3.22* 42 ± 2.87* 
RBC(Million/c
u.mm) 
5.3±0.12 2.7±0.17# 4.1±0.23* 3.9±0.32* 
 
Values were expressed as mean ± SD for six rats in each group.  
* Significantly different from Group II (p< 0.001) 
 #  Significantly different from Group I  (p< 0.001) 
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Table 31: Effect of Panchakkini Chenduram on WBC and Platelet count in 
experimental rats 
 
Parameters Control 
Phenylhydrazi
ne (40mg/kg) 
   
PC(10m
g/kg) 
Hematinic 
syrup(0.68ml/
kg/day) 
WBC(cu.mm) 4567±276 2457±254# 
3567±23
4* 
3425±275* 
Platelet(cu.mm) 
350000 ± 
3652 
120000 ± 
 9567# 
280000 ± 
4532* 
222000 ±  
 0.04* 
 
Values were expressed as mean ± SD for six rats in each group. 
 * Significantly different from Group II (p< 0.001)   
#  Significantly different from Group I  (p< 0.001) 
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Table 32 : 
Parameters Control 
Phenylhyd
razine 
(40mg/kg) 
   
PC(10mg/
kg) 
Hematinic 
syrup(0.68ml/
kg/day) 
SGOT (IU/L)   
 
25.28 
±63.90  
 
 
91.88 
±22.16#  
 
35.02±13.9
* 
 40.64± 15.50*   
 
Values were expressed as mean ± SD for six rats in each group.  
* Significantly different from Group II (p< 0.01)  
#  Significantly different from Group I  (p< 0.001) 
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Table 33:Effect of Panchakkini Chenduram on MCH, MCHC and MCV count in 
experimental rats 
Parameters Control 
Phenylhydrazine 
(40mg/kg) 
PC(10mg/
kg) 
Hematinic 
syrup(0.68ml/
kg/day) 
MCH (pg/cell) 26.34± 1.87 23.92 ± 1.60# 
28.81 ± 
2.24* 
29.55 ± 2.22* 
MCHC (%) 31.43± 2.55 16.27 ± 1.24# 
31.61 ± 
2.24* 
32.97 ± 2.78* 
MCV  (Cubic 
micron) 
82.58 ± 5.29  115.23 ±8.27#  100 ± 7*  101.84±7.29* 
 
Values were expressed as mean ± SD for six rats in each group.   
* Significantly different from Group II (p< 0.01)  
  #  Significantly different from Group I  (p< 0.01)   
 
Chart- 36 
 
Interpretation: 
Results of study were represented in Table- 30, 31, 32 and 33 . Anemia is one the 
numerous ailments calimed to been successfully treated with minerals by traditional 
medicine practitioners. Many minerals products are used to treat the Anemia. Keeping in 
view in the present study was evaluated the anti- anemic activity of Panchakkini 
Chenduram Medicine. Phenlihydrazine, a alkylhydrazine was chosen to induce 
haemolytic anemia. The results of the present study concluded that Panchakkini 
Chenduram medicine inhibits anemia induced by phenylhydrazine. The anti- anaemic 
potential of Panchakkini Chenduram medicine for management of anemia.  
0
50
100
150
MCH, MCHC and MCV
MCH(pg/cell)
MCHC(%)
MCV(cubic micron)
 
 
 
 
 
 
DISCUSSION 
124 
 
8. DISCUSSION 
 
      The well known folklore medicine Panchakkini Chenduram had been subjected to 
various studies and it confirms the literature evidences. Literary collections, 
Physicochemical Studies, Bio-chemical analysis, Toxicity studies, Pharmacological 
studies were done to prove the Hepatoprotective, Diuretic and Hematinic activities of 
Panchakkini Chenduram. Literary review about the ingredients of Panchakkini 
Chenduram from various text books give hope about its activity. The studies strongly 
substantiated textual references and as discussed below.  
 
Literary collections:  
 Literary collections include drug review, which consist Siddha aspect, 
pharmaceutical and pharmacological review are support for this study.  
 
Drug review:  
 
Drug review about the ingredients of   Panchakkini Chenduram from various text 
books was done. Gunapadam aspect expressed that the Panchakkini Chenduram possess 
Hepatoprotective, Diuretic and Hematinic property. 
 
Physico chemical analysis:  
 
The pH of the drug was 8.2. It denotes it is slightly alkaline. Hence, in the oral 
administration of the drug it may it indicates that drug will get ionized in stomach and 
will be absorbed in intestine and directly sent to portal system.Loss on drying of 
Panchakkini Chenduram at 105°Cis 2.353 %. It indicates the loss of volatile substances 
along with the water this reveals that drug will not lose much of its volume and volatile 
substance. It shows that the drug has more stability. Ash value 70.56% it is the residue 
remaining after incineration that determines the inorganic substances present in the drug. 
Similarly it can also detect the nature of the material, whether it is adulterate or not. 
Hence, determination of the ash value provides an idea for judging the identity and purity 
of the drug 
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Biochemical analysis: 
In bio chemical analysis the results shows that the presence of Silicate, Phosphate, 
Iron and Magnesium. 
 
Toxicity studies:  
 
In Acute toxicity study there is no mortality was observed in animals.  Based on 
OECD 423 the trail drug Panchakkini Chenduram is considered as non toxic up to the 
dose of 2000mg/kg.  
 
The Repeated dose 28 day oral toxicity (OECD - 407)and Repeated dose 90-day 
oral toxicity study (OECD – 408) of Panchakkini Chenduram in  Wistar  albino rats were  
studied. The treated animals survived throughout the study period of 28 days and 90 days 
did not reveal any treatment related major abnormal clinical signs at the test dose levels. 
The overall percentage of body weight gain in rats treated with the drug was found to be 
normal indicating that the test animals were in a healthy condition during the 90 days of 
observation period. The P values of haematological parameters and biochemical 
parameters of the tested rats were not significant indicating that the drug exerted nil 
impact on the parameters and they were within the reference range. In histopathological 
study on UC high dose treated rats. The necropsy studies showed no remarkable changes.   
This strongly stress the fact of the drug having no toxic effect on the body 
metabolism.The necropsy studies showed no remarkable changes. So the trial drug 
Panchakkini Chenduram can hopefully used for human trails. 
 
Pharmacological studies:  
[ 
 The pharmacological activities like Hepatoprotective, Diuretic, and Hematinic   
activity of Panchakkini Chendrum shown significant effect.  
 
Hepatoprotective activity  
 
Hepatoprotective activity was carried out in Paracetamol induced Wistar albino 
rats. Paracetamol induced hepatotoxicity is the generally used screening method for 
testing the hepatoprotective nature of drugs. The effects observed were compared with a 
known hepatoprotective agent, silymarin. In the acute liver damage induced by different 
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hepatotoxins, Panchakkini Chenduram (5 and 10mg/kg, po) significantly reduced the 
elevated serum levels of aspartate aminotransferase, alanine aminotransferase, alkaline 
phosphatase and bilirubin. The higher dose of the PCM (1 mg/kg, po) prevented the 
increase in liver weight when compared to hepatoxin treated control, while the lower dose 
was ineffective except in the paracetamol induced liver damage. Histological examination 
of the liver tissues supported the hepatoprotection. It is concluded that the the 
Panchakkini Chenduram possesses good hepatoprotective activity. From the blood 
samples collected PCV, Hb concentration, MCV, MCH, MCHC,RBC and WBC count 
were determined. 
 
Diuretic activity 
      
The Diuretic activity of panchakkini Chenduram is done in Wistar albino rats by 
Lipschitz test induced method.Wistar rats were divided into five groups, consisting six 
rats for each group. Group (I) served as normal control (Vehicle) which receivedSaline 
water (10 ml/kg orally) only. Group II received as furosemide orally dose of (10mg/kg, 
p.o) Groups (III) to (V) received Panchakkini Chenduram respectively at dose of 
2.5mg/kg, 5mg/kg and 10 mg/kg respectively. Immediately after the extract treatment, all 
the rats are hydrated with saline (15 ml/kg) and placed in a metabolic cages. A total 
volume of urine collected for 6 hours was measured at the end. During this period no food 
and water were made available to animals. Various parameters like total urine volume and 
concentration of sodium, potassium and chloride in the urine were measured and 
estimated respectively.Estimation of urine output is expressed as ml/kg.   
 
Hematinic activity 
 
Diuretic activity was carried out in Phenylhydrazine injection intraperitoneally to 
induced anemia in Wister albino rats, the rat were divided into 4 groups of 6 rats each. Ist 
group act as control, IInd group received PHZ, IIIrd group received Panchakkini 
Chenduram,IVth group received standard as hematinic syrup. On collecting the blood 
sample, it is concluded that HB, RBC, WBC, Platelet, PCV, MCV, MCHC decreased in 
group II compared to group I, increased in group III compared to group II, except SGOT. 
This result supports atleast partially used to anaemia. 
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ANALYSIS STUDIES 
 
Ø The Fourier Transform Infrared Spectroscopy (FTIR) analysis of  
Panchakkini Chenduram shows Strong intense peak at 466.11 cm-1 may be due to 
Fe- S stretching indicates the presence of Fe-S group and also shows present of 
functional groups such as alcohol, carbonyl, amine, amide, sulfide, disulfide, 
ferrous sulfide. 
Ø X-Ray Diffraction (XRD) analysis of the Panchakkini Chenduram shows 
intensity peaks of various places. The peaks were identified as crystalline peaks. 
Ø The High resonance scanning Electron microscopy (HR-SEM) analysis shows 
the shape of Panchakkini Chenduram. The micrograph reveals the information on 
external morphology, texture and orientation of materials making up the sample. 
Ø Ultraviolet – Visible Spectroscopy analysis shows the λ max value of the sample 
Panchakkini Chenduram projects intense absorbance at 302.72 nm and 384.33 
nm.Also presents of sulfide and Iron oxide.  
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9. SUMMARY 
 
Ø The selection of the drug Panchakkini  Chenduram from the literature “Anuboga 
vaidya navaneetham” part 1, page no 92, Hakkim Abdulla shayabu, for the 
evaluation of Hepatoprotective, Diuretic  and Hematinic activities. 
Ø The test drug was prepared by the given procedure. All the ingredients were 
identified and authenticated by the experts. 
Ø Review of literature in various categories was carried out Siddha aspect and 
pharmaceutical review disclosed about the drug and the disease. The 
pharmacological review was done to establish the methodologies. 
Ø Since the ingredients of Panchakkini Chenduram purified according to the           
classical methods. The purification process of this drug possible to eliminate their 
toxins and increases its efficacy and the grinding process of this drug helps to 
reduce the particle size of the drug for its better bio availability. 
Ø The drug was subjected to analysis such as physicochemical, chemical and also 
instrumental analysis which provided the key ingredients present in the drug thus 
it accounts the efficacy of the drug. 
Ø Toxicological study was made according to OECD guidelines comprising acute, 
sub-acute and sub chronic toxicity study. It screens the safety of the drug which 
attributes its utility in long time administration. 
Ø Pharmacological study was done. It revealed the Hepatoprotective, Diuretic and 
Hematinic activities of Panchakkini Chenduram in Wistar albino rat model. 
Ø Results and discussion given the necessary justification to prove the potency of 
the drug. 
Ø Conclusion gives a compiled form of the study and explains the synergistic effect 
of all the key ingredients and activities that supports the study. 
Ø Thus the mineral formulation Panchakkini Chenduram is validated for its safety 
and efficacy for treating Liver disesses, Oliguria and Anaemia it would be a great 
drug of choice. 
 
 
 
 
 
 
 
 
 
CONCLUSION 
129 
 
10. CONCLUSION 
 
From the literature evidence, Physico Chemical Analysis, Chemical Analysis, 
Toxicological evaluation and pharmacological  studies, the drug  Panchakkini Chenduram 
have Hepatoprotective, Diuretic,  Hematinic activity it was concluded that the 
Panchakkini Chenduram can be issued in the management Liver diseases, Oliguria, and 
Anaemia.  
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